<SEC-DOCUMENT>0001021771-23-000010.txt : 20230207
<SEC-HEADER>0001021771-23-000010.hdr.sgml : 20230207
<ACCEPTANCE-DATETIME>20230207180056
ACCESSION NUMBER:		0001021771-23-000010
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20230207
DATE AS OF CHANGE:		20230207

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BioRestorative Therapies, Inc.
		CENTRAL INDEX KEY:			0001505497
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				911835664
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-269631
		FILM NUMBER:		23596409

	BUSINESS ADDRESS:	
		STREET 1:		40 MARCUS DRIVE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		(631) 760-8100

	MAIL ADDRESS:	
		STREET 1:		40 MARCUS DRIVE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Stem Cell Assurance, Inc.
		DATE OF NAME CHANGE:	20101110
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>s3dtd020723.htm
<DESCRIPTION>COMMON STOCK, PREFERRED STOCK, WARRANTS, DEBT SECURITIES AND UNITS
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Certilman Balin Adler & Hyman, LLP
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">As filed with the Securities and Exchange Commission on February 7, 2023</div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-weight: bold;">Registration No. 333-</div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto; border: medium none;"></div>
    <div style="text-align: center; margin-top: 4pt; font-family: 'Times New Roman'; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Washington, D.C. 20549</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">____________________</div>
    <div style="text-align: center; margin-top: 12pt; font-family: 'Times New Roman'; font-weight: bold;">Form S-3</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">REGISTRATION STATEMENT</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">UNDER</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">THE SECURITIES ACT OF 1933</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">____________________</div>
    <div style="text-align: center; margin-top: 12pt; font-family: 'Times New Roman'; font-weight: bold;">BIORESTORATIVE THERAPIES, INC.</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">(Exact name of registrant as specified in its charter)</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">____________________</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z7768904728854ca9aa19ac37459c8017" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 62.37%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; font-weight: bold;">Nevada</div>
          </td>
          <td style="width: 0.18%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 37.45%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; font-weight: bold;">91-1835664</div>
          </td>
        </tr>
        <tr>
          <td style="width: 62.37%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">(State or other jurisdiction of</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">incorporation or organization)</div>
          </td>
          <td style="width: 0.18%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 37.45%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">(I.R.S. Employer</div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Identification No.)</div>
          </td>
        </tr>

    </table>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">40 Marcus Drive, Suite One</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Melville, New York 11747</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">(631) 760-8100</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(Address, including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</font></div>
    <div style="text-align: center; margin-top: 3pt; font-family: 'Times New Roman'; font-weight: bold;">____________________</div>
    <div style="margin-top: 3pt; font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Lance Alstodt, President and Chief Executive Officer</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">BioRestorative Therapies, Inc.</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">40 Marcus Drive, Suite One</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Melville, New York 11747</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">(631) 760-8100</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: bold;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(Name, address, including zip code, and telephone number, including area code, of agent for service)</font></div>
    <div style="text-align: center; margin-top: 3pt; font-family: 'Times New Roman'; font-weight: bold;">____________________</div>
    <div style="text-align: center; margin-top: 12pt; font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">Copies of all communications, including communications sent to agent for service, should be sent to:</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Fred Skolnik, Esq.</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Certilman Balin Adler &amp; Hyman, LLP</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">90 Merrick Avenue</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">East Meadow, New York 11554</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">(516) 296-7000</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">____________________</div>
    <div style="text-indent: 36pt; margin-top: 12pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman'; font-weight: bold;">Approximate date of
        commencement of proposed sale to the public:</font><font style="font-family: 'Times New Roman';"> From time to time after the effective date of this registration statement.</font></div>
    <div style="text-indent: 36pt; margin-top: 12pt; font-family: 'Times New Roman';">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans,
      please check the following box. &#9744;</div>
    <div style="text-indent: 36pt; margin-top: 12pt; font-family: 'Times New Roman';">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule
      415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. &#8999;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="text-indent: 36pt; margin-top: 12pt; font-family: 'Times New Roman';">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act,
      check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</div>
    <div style="text-indent: 36pt; margin-top: 12pt; font-family: 'Times New Roman';">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box
      and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</div>
    <div style="text-indent: 36pt; margin-top: 12pt; font-family: 'Times New Roman';">If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that
      shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. &#9744;</div>
    <div style="text-indent: 36pt; margin-top: 12pt; font-family: 'Times New Roman';">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to
      register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. &#9744;</div>
    <div style="text-indent: 36pt; margin-top: 12pt; font-family: 'Times New Roman';">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a
      smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zc90b2e6adde94525973e5cd86f0e6243" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 21.94%; vertical-align: top; font-family: 'Times New Roman';">
            <div>Large accelerated filer</div>
          </td>
          <td style="width: 45.73%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9744;</div>
          </td>
          <td style="width: 26.42%; vertical-align: top; font-family: 'Times New Roman';">
            <div>Accelerated filer</div>
          </td>
          <td style="width: 5.91%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 21.94%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 45.73%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 26.42%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 5.91%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        </tr>
        <tr>
          <td style="width: 21.94%; vertical-align: top; font-family: 'Times New Roman';">
            <div>Non-accelerated filer</div>
          </td>
          <td style="width: 45.73%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#8999;</div>
          </td>
          <td style="width: 26.42%; vertical-align: top; font-family: 'Times New Roman';">
            <div>Smaller reporting company</div>
          </td>
          <td style="width: 5.91%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#8999;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 21.94%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 45.73%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 26.42%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 5.91%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        </tr>
        <tr>
          <td style="width: 21.94%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 45.73%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 26.42%; vertical-align: top; font-family: 'Times New Roman';">
            <div>Emerging growth company</div>
          </td>
          <td style="width: 5.91%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9744;</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">____________________</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
      with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman'; font-weight: bold;">The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective
      date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act, or until this registration statement shall
      become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.</div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto; border: medium none;"></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(255, 0, 0);">The information in this prospectus is not complete and may be changed. We may not sell these
      securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state or
      jurisdiction where the offer or sale is not permitted.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">Subject to Completion, dated February 7, 2023</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="font-family: 'Times New Roman'; font-weight: bold;">PROSPECTUS</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">BIORESTORATIVE THERAPIES, INC.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: center; margin-bottom: 6pt; font-family: 'Times New Roman'; font-weight: bold;">$75,000,000</div>
    <div style="text-align: center; margin-bottom: 6pt; font-family: 'Times New Roman'; font-weight: bold;">Common Stock</div>
    <div style="text-align: center; margin-bottom: 6pt; font-family: 'Times New Roman'; font-weight: bold;">Preferred Stock</div>
    <div style="text-align: center; margin-bottom: 6pt; font-family: 'Times New Roman'; font-weight: bold;">Warrants</div>
    <div style="text-align: center; margin-bottom: 6pt; font-family: 'Times New Roman'; font-weight: bold;">Debt Securities</div>
    <div style="text-align: center; margin-bottom: 6pt; font-family: 'Times New Roman'; font-weight: bold;">Units</div>
    <div style="text-align: center; margin-bottom: 6pt; font-family: 'Times New Roman';">____________________</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">We may offer, issue and sell, from time to time, in one or more offerings, the securities described in this prospectus.&#160; The aggregate initial
      offering price of all securities sold under this prospectus by us will not exceed $75,000,000.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">This prospectus describes the general terms of our securities and the general manner in which our securities will be offered by us. We will
      provide the specific terms of these offerings in supplements to this prospectus. We may authorize one or more free writing prospectuses to be provided to you in connection with these offerings. The applicable prospectus supplement and any related
      free writing prospectus may also add, update or change information contained or incorporated by reference in this prospectus. <font style="font-weight: bold;">You should carefully read this prospectus, the applicable prospectus supplement and any
        related free writing prospectus, as well as any documents incorporated by reference, before buying any of the securities being offered.</font></div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">We may offer securities in amounts, at prices and on terms determined at the time of offering.&#160; Our securities may be sold directly to you,
      through agents, or through underwriters and dealers. If agents, underwriters or dealers are used to sell our securities, we will name them and describe their compensation in a prospectus supplement.&#160; No securities may be sold without delivery of this
      prospectus and the applicable prospectus supplement describing the method and terms of the offering of such securities.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">Our common stock is listed on the Nasdaq Capital Market under the symbol &#8220;BRTX.&#8221;</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">As of February 6, 2023, the aggregate market value of our outstanding common stock held by non-affiliates, or the public float, was $8,900,824,
      based on 3,679,847 shares of common stock outstanding, of which 2,889,878 shares were held by non-affiliates, and a price of $3.08 per share, which was the last reported sale price of our common stock on the Nasdaq Capital Market on February 6, 2023.
      Pursuant to General Instruction&#160;I.B.6&#160;of Form S-3, in no&#160;event will we sell shares pursuant to this prospectus with a value of more than one-third of the aggregate market value of our common stock held by non-affiliates in any 12-month period, so
      long as the aggregate market value of our common stock held by non-affiliates is less than $75,000,000.&#160; During the 12 calendar months prior to, and including, the date of this prospectus, we have not sold securities pursuant to General
      Instruction&#160;I.B.6 of Form S-3.</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"> <font style="font-size: 10pt;"><br>
      </font></div>
    <div style="text-align: center; font-family: 'Times New Roman';">____________________ </div>
    <div style="text-align: center; margin-top: 3pt; font-family: 'Times New Roman';"><br>
    </div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman'; font-weight: bold;">Investing in our securities involves a high degree of risk. You should review carefully the risks and uncertainties
      described under the heading &#8220;<a href="#RISKFACTORS">Risk Factors</a>&#8221; on page 4 and contained in the applicable prospectus supplement and any related free writing prospectus, and under similar headings in the other documents that are incorporated by
      reference in this prospectus.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman'; font-weight: bold;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these
      securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman'; font-weight: bold;">This prospectus may not be used to consummate sales of securities unless accompanied by a prospectus supplement.</div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman';">
      <div>____________________ </div>
    </div>
    <div style="text-align: center;"><font style="font-family: 'Times New Roman'; font-weight: bold;">The date of this prospectus is</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 252pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman'; font-weight: bold;">, 2023.</font></div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><a name="TABLEOFCONTENTS"><!--Anchor--></a>TABLE OF CONTENTS</div>
    <div style="font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z03d57789076a4a47b42142d49a191c5a" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 91.44%; vertical-align: top; font-family: 'Times New Roman'; background-color: rgb(204, 238, 255);">&#160;</td>
          <td style="width: 8.56%; vertical-align: top; font-family: 'Times New Roman'; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; font-weight: bold;">Page</div>
          </td>
        </tr>
        <tr>
          <td style="width: 91.44%; vertical-align: top; font-family: 'Times New Roman';">
            <div><a href="#WHEREYOUCANOBTAINMOREINFO">About This Prospectus</a><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 12pt;">&#160;</font></div>
          </td>
          <td style="width: 8.56%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">1</div>
          </td>
        </tr>
        <tr>
          <td style="width: 91.44%; vertical-align: top; font-family: 'Times New Roman'; background-color: rgb(204, 238, 255);">
            <div><a href="#WHEREYOUCANOBTAINMOREINFO">Where You Can Obtain More Information</a><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 12pt;">&#160;</font></div>
          </td>
          <td style="width: 8.56%; vertical-align: top; font-family: 'Times New Roman'; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;">2</div>
          </td>
        </tr>
        <tr>
          <td style="width: 91.44%; vertical-align: top; font-family: 'Times New Roman';">
            <div><a href="#INCORPORATIONOFCERTAININF">Incorporation of Certain Information by Reference</a><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 12pt;">&#160;</font></div>
          </td>
          <td style="width: 8.56%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">2</div>
          </td>
        </tr>
        <tr>
          <td style="width: 91.44%; vertical-align: top; font-family: 'Times New Roman'; background-color: rgb(204, 238, 255);">
            <div><a href="#RISKFACTORS">Risk Factors</a><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 12pt;">&#160;</font></div>
          </td>
          <td style="width: 8.56%; vertical-align: top; font-family: 'Times New Roman'; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;">4</div>
          </td>
        </tr>
        <tr>
          <td style="width: 91.44%; vertical-align: top; font-family: 'Times New Roman';">
            <div><a href="#SPECIALCAUTIONARYNOTEREGA">Special Cautionary Note Regarding Forward-Looking Statements</a></div>
          </td>
          <td style="width: 8.56%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">4</div>
          </td>
        </tr>
        <tr>
          <td style="width: 91.44%; vertical-align: top; font-family: 'Times New Roman'; background-color: rgb(204, 238, 255);">
            <div><a href="#THECOMPANY">The Company</a><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 12pt;">&#160;</font></div>
          </td>
          <td style="width: 8.56%; vertical-align: top; font-family: 'Times New Roman'; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;">5</div>
          </td>
        </tr>
        <tr>
          <td style="width: 91.44%; vertical-align: top; font-family: 'Times New Roman';">
            <div><a href="#USEOFPROCEEDS">Use of Proceeds</a><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 12pt;">&#160;</font></div>
          </td>
          <td style="width: 8.56%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">6</div>
          </td>
        </tr>
        <tr>
          <td style="width: 91.44%; vertical-align: top; font-family: 'Times New Roman'; background-color: rgb(204, 238, 255);">
            <div><a href="#DESCRIPTIONOFSECURITIESWE">Description of Securities We May Offer<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 12pt;">&#160;</font></a></div>
          </td>
          <td style="width: 8.56%; vertical-align: top; font-family: 'Times New Roman'; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;">6</div>
          </td>
        </tr>
        <tr>
          <td style="width: 91.44%; vertical-align: top; font-family: 'Times New Roman';">
            <div><a href="#PLANOFDISTRIBUTION">Plan of Distribution</a><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 12pt;">&#160;</font></div>
          </td>
          <td style="width: 8.56%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">18</div>
          </td>
        </tr>
        <tr>
          <td style="width: 91.44%; vertical-align: top; font-family: 'Times New Roman'; background-color: rgb(204, 238, 255);">
            <div><a href="#LEGALMATTERS">Legal Matters</a><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 12pt;">&#160;</font></div>
          </td>
          <td style="width: 8.56%; vertical-align: top; font-family: 'Times New Roman'; background-color: rgb(204, 238, 255);">
            <div style="text-align: center;">19</div>
          </td>
        </tr>
        <tr>
          <td style="width: 91.44%; vertical-align: top; font-family: 'Times New Roman';">
            <div><a href="#EXPERTS">Experts</a><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 12pt;">&#160;</font></div>
          </td>
          <td style="width: 8.56%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">20</div>
          </td>
        </tr>

    </table>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%%%-->
    <div style="font-family: 'Times New Roman',Times,serif; font-weight: 400;"><a name="ABOUTTHISPROSPECTUS"><!--Anchor--></a><a href="#TABLEOFCONTENTS">Table of Contents</a><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;">ABOUT THIS PROSPECTUS</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission, referred to
      as the SEC, using a &#8220;shelf&#8221; registration process. Under this shelf registration process, we may from time to time offer and sell any of the securities or any combination of the securities described in this prospectus in one or more offerings up to a
      total dollar amount not to exceed $75,000,000.</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">This prospectus provides you with a general description of the securities we may offer. Each time we sell securities, we
      will provide a prospectus supplement that will contain specific information about the terms of that offering. Such prospectus supplement may also add, update or change information contained in this prospectus. If there is any inconsistency between
      the information in this prospectus and the applicable prospectus supplement, you should rely on the information in the prospectus supplement. You should read the information in this prospectus, the applicable prospectus supplement, any free writing
      prospectus that we authorize for use in connection with this offering and the additional information incorporated by reference herein as provided for under the heading &#8220;Incorporation of Certain Information by Reference.&#8221;</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">You should rely only on the information contained or incorporated by reference in this prospectus, any applicable
      prospectus supplement and any free writing prospectuses that we authorize for use in connection with this offering. We have not authorized anyone to provide you with different or additional information. If anyone provides you with different or
      additional information, you should not rely on it. We are not making an offer to sell the securities in any jurisdiction where the offer or sale is not permitted or in which the person making such offer or solicitation is not qualified to do so or to
      any person to whom it is unlawful to make such offer or solicitation. You should not assume that the information contained or incorporated by reference in this prospectus, any prospectus supplement, or any free writing prospectus that we authorize
      for use in connection with this offering is accurate or complete as of any date other than the dates of the applicable documents. Our business, financial condition, liquidity, results of operations and prospects may have changed since those dates.</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">This prospectus contains summaries of certain provisions contained in some of the documents described herein, but
      reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be
      incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below under the heading &#8220;Where You Can Obtain More Information.&#8221; As permitted by the
      rules and regulations of the SEC, the registration statement that contains this prospectus includes additional information not contained in this prospectus. You may read the registration statement and the other reports we file with the SEC at the
      SEC&#8217;s web site or at the SEC&#8217;s offices described below under the heading &#8220;Where You Can Obtain More Information.&#8221;</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">Unless the context of this prospectus indicates otherwise, the terms &#8220;BioRestorative,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;
      refer to BioRestorative Therapies, Inc. and its subsidiaries.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">1</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;"><a name="WHEREYOUCANOBTAINMOREINFO"><!--Anchor--></a></div>
    <div style="margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;"> <a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a></div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;">WHERE YOU CAN OBTAIN MORE INFORMATION</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">We are subject to the information requirements of the Securities Exchange Act of 1934, as amended, referred to as the
      Exchange Act, which means that we are required to file annual, quarterly and current reports, proxy statements and other information with the SEC, all of which are available at the Public Reference Room of the SEC at 100 F Street, NE, Washington D.C.
      20549. You may also obtain copies of these reports, proxy statements and other information from the Public Reference Room of the SEC, at prescribed rates, by calling 1-800-SEC-0330. The SEC maintains an Internet website at http://www.sec.gov where
      you can access reports, proxy statements, information and registration statements, and other information regarding us that we file electronically with the SEC. In addition, we make available, without charge, through our website,
      www.biorestorative.com, electronic copies of various filings with the SEC, including copies of Annual Reports on Form 10-K. Information on our website should not be considered a part of this prospectus, and we do not intend to incorporate in this
      prospectus any information contained on our website.</div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;"><a name="INCORPORATIONOFCERTAININF"><!--Anchor--></a>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">The SEC allows us to &#8220;incorporate by reference&#8221; the information we file with it, which means that we can disclose
      important information to you by referring to those documents filed separately with the SEC. The information we incorporate by reference is an important part of this prospectus. We incorporate by reference the documents listed below, except to the
      extent that any information contained in those documents is deemed &#8220;furnished&#8221; in accordance with SEC rules.</div>
    <table cellspacing="0" cellpadding="0" id="zc7227195599241da838c09b76785880e" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 12.41%; vertical-align: top;">
            <div style="margin-bottom: 12pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">&#8226;</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 9pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">&#160;</font></div>
          </td>
          <td style="width: 87.59%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1505497/000149315222008184/0001493152-22-008184-index.htm">Our Annual Report on Form 10-K for the year ended December 31, 2021</a>;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12.41%; vertical-align: top;">
            <div style="margin-bottom: 12pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">&#8226;</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 9pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">&#160;</font></div>
          </td>
          <td style="width: 87.59%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1505497/000149315222013396/0001493152-22-013396-index.htm">Our Quarterly Report on Form 10-Q for the quarter ended March 31, 2022</a>;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12.41%; vertical-align: top;">
            <div style="margin-bottom: 12pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">&#8226;</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 9pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">&#160;</font></div>
          </td>
          <td style="width: 87.59%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1505497/000149315222022617/0001493152-22-022617-index.htm">Our Quarterly Report on Form 10-Q for the quarter ended June 30, 2022</a>;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12.41%; vertical-align: top;">
            <div style="margin-bottom: 12pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">&#8226;</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 9pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">&#160;</font></div>
          </td>
          <td style="width: 87.59%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1505497/000149315222031668/0001493152-22-031668-index.htm">Our Quarterly Report on Form 10-Q for the quarter ended September 30, 2022</a>;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12.41%; vertical-align: top;">
            <div style="margin-bottom: 12pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">&#8226;</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 9pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">&#160;</font></div>
          </td>
          <td style="width: 87.59%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1505497/000102177122000051/0001021771-22-000051-index.htm">Our Current Report on Form 8-K filed on September 13, 2022</a>;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12.41%; vertical-align: top;">
            <div style="margin-bottom: 12pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">&#8226;</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 9pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">&#160;</font></div>
          </td>
          <td style="width: 87.59%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1505497/000102177122000060/0001021771-22-000060-index.htm">Our Current Report on Form 8-K filed on November 9, 2022</a>;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12.41%; vertical-align: top;">
            <div style="margin-bottom: 12pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">&#8226;</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 9pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">&#160;</font></div>
          </td>
          <td style="width: 87.59%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: justify;"><a href="https://www.sec.gov/Archives/edgar/data/1505497/000102177123000002/0001021771-23-000002-index.htm">Our Current Report on Form 8-K filed on January 5, 2023</a>;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12.41%; vertical-align: top;">
            <div style="margin-bottom: 12pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">&#8226;</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 9pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">&#160;</font></div>
          </td>
          <td style="width: 87.59%; vertical-align: top; font-family: 'Times New Roman';">
            <div><a href="https://www.sec.gov/Archives/edgar/data/1505497/000102177121000082/0001021771-21-000082-index.htm">The description of our common stock contained in our registration statement on Form 8-A filed
                with the SEC on November 4, 2021 (File No. 001-37603), and any amendment or report filed with the SEC for the purpose of updating the description</a>.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12.41%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 87.59%; vertical-align: top; font-family: 'Times New Roman';" rowspan="1">&#160;</td>
        </tr>

    </table>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">We also incorporate by reference additional documents that we will file with the SEC pursuant to Section 13(a), 13(c), 14
      or 15(d) of the Exchange Act prior to the termination of the offering under this prospectus. Those documents include periodic reports such as Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, as well as
      proxy statements on Schedule DEF 14A.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a>
      <div><br>
      </div>
    </div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">Any statement contained in a document that is incorporated by reference will be modified or superseded for all purposes to
      the extent that a statement contained in this prospectus, any prospectus supplement or any free writing prospectus that we authorize for use in connection with this offering modifies or is contrary to that previous statement. Any statement so
      modified or superseded will not be deemed a part of this prospectus or any prospectus supplement except as so modified or superseded.</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">Documents which we incorporate by reference are available from us without charge, excluding all exhibits, unless we have
      specifically incorporated by reference an exhibit in this prospectus. You may obtain documents incorporated by reference in this prospectus by requesting them in writing or by telephone from us at:</div>
    <div style="text-align: center; font-family: 'Times New Roman';">BioRestorative Therapies, Inc.</div>
    <div style="text-align: center; font-family: 'Times New Roman';">40 Marcus Drive, Suite One</div>
    <div style="text-align: center; font-family: 'Times New Roman';">Melville, New York 11747</div>
    <div style="text-align: center; font-family: 'Times New Roman';">(631) 760-8100</div>
    <div style="text-align: center; font-family: 'Times New Roman';">Attention: Secretary</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;"><a name="RISKFACTORS"><!--Anchor--></a></div>
    <div style="margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;"> <a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a></div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;">RISK FACTORS</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-style: italic;">An investment in our securities involves a high degree of risk. Prior to making a decision about
      investing in our securities, you should consider carefully the specific risk factors discussed in the section entitled &#8220;Management&#8217;s Discussion and Analysis of Financial Conditions and Results of Operations - Factors That May Affect Future Results
      and Financial Condition&#8221; contained in our most recent Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the SEC, and which is incorporated in this prospectus by reference in its entirety, as well as any amendment or
      updates to our risk factors reflected in subsequent filings with the SEC, including any prospectus supplement hereto. These risks and uncertainties are not the only risks and uncertainties we face. Additional risks and uncertainties not presently
      known to us, or that we currently view as immaterial, may also impair our business. If any of the risks or uncertainties described in our SEC filings or any additional risks and uncertainties actually occur, our business, financial condition, results
      of operations and cash flow could be materially and adversely affected. In that case, the trading price of our securities could decline and you might lose all or part of your investment. Please also refer to the section below entitled &#8220;Special
      Cautionary Note Regarding Forward-Looking Statements.&#8221;</div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;"><a name="SPECIALCAUTIONARYNOTEREGA"><!--Anchor--></a>SPECIAL CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</div>
    <div style="font-family: 'Times New Roman';">
      <div style="text-indent: 36pt;">Some of the statements in or incorporated by reference into this prospectus contain &#8220;forward-looking statements.&#8221; Forward-looking statements are made based on our management&#8217;s expectations and beliefs
        concerning future events impacting our company and are subject to uncertainties and factors relating to our operations and economic environment, all of which are difficult to predict and many of which are beyond our control. You can identify these
        statements from our use of the words &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;target,&#8221; &#8220;plan,&#8221; &#8220;may&#8221; and similar expressions. These forward-looking statements may include, among other things:</div>
    </div>
    <div style="font-family: 'Times New Roman';">
      <div style="text-align: justify; text-indent: 22.5pt;">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z9fa5122519ae48eabff1c37da2ab97c9" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: justify;">&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman';">
            <div>statements relating to projected growth and management&#8217;s long-term performance goals;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: justify;">&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top;">
            <div style="font-family: 'Times New Roman';">statements relating to the anticipated effects on results of operations or our financial condition</div>
            <div style="font-family: 'Times New Roman';">from expected developments or events;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: justify;">&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: justify;">statements relating to our business and growth strategies; and</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: justify;">&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: justify;">any other statements which are not historical facts.</div>
          </td>
        </tr>

    </table>
    <div style="font-family: 'Times New Roman';">
      <div style="text-align: justify; text-indent: 22.5pt;">&#160;</div>
    </div>
    <div style="font-family: 'Times New Roman';">
      <div style="text-indent: 36pt;">Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ
        materially from our expectations of future results, performance or achievements expressed or implied by these forward-looking statements. These forward-looking statements may not be realized due to a variety of factors, including without
        limitation:</div>
    </div>
    <div style="font-family: 'Times New Roman';">
      <div style="text-indent: 22.5pt;">&#160;</div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z2f2269a579e447fbb7fccd9c28bdffd8" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman';">
            <div>our current and anticipated cash needs and our need for additional financing;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman';">
            <div>federal, state and foreign regulatory requirements;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman';">
            <div>our ability to conduct clinical trials with respect to our products and services;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman';">
            <div>our ability to develop and commercialize our products and services;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman';">
            <div>our ability to enter into agreements to implement our business strategy;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman';">
            <div>the acceptance of our products and services by patients and the medical community;</div>
          </td>
        </tr>

    </table>
    <font style="font-family: 'Times New Roman';">
    </font>
    <div><font style="font-family: 'Times New Roman';"><br>
      </font>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber"> <br>
        </font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div><a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a></div>
    <div><br>
    </div>
    <font style="font-family: 'Times New Roman';">
    </font>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top;">
            <div style="font-family: 'Times New Roman';">our ability to secure necessary media and reagents, as well as devices, materials and systems,</div>
            <div style="font-family: 'Times New Roman';">for our clinical trials and commercial production;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman';">
            <div>our manufacturing capabilities to produce our products;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman';">
            <div>our ability to obtain brown adipose (fat) tissue in connection with our&#160;<font style="font-style: italic;">ThermoStem Program</font>;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman';">
            <div>our ability to protect our intellectual property;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman';">
            <div>our ability to obtain and maintain an adequate level of product liability insurance;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top;">
            <div style="font-family: 'Times New Roman';">our ability to obtain third party reimbursement for our products and services from private and</div>
            <div style="font-family: 'Times New Roman';">governmental insurers;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman';">
            <div>the effects of competition in our market areas;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman';">
            <div>our reliance on certain key personnel;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman';">
            <div>further sales or other dilution of our equity, which may adversely affect the market price of our securities; and</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 2.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 95%; vertical-align: top; font-family: 'Times New Roman';">
            <div>other factors and risks referred to under &#8220;<a href="#RISKFACTORS">Risk Factors</a>&#8221; on page 4 of this prospectus.</div>
          </td>
        </tr>

    </table>
    <div style="font-family: 'Times New Roman';">
      <div>&#160;</div>
    </div>
    <div style="font-family: 'Times New Roman';">
      <div style="text-indent: 36pt;">You should not place undue reliance on any forward-looking statement. We undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date of this
        prospectus or to reflect the occurrence of unanticipated events.</div>
      <div style="text-indent: 36pt;"> <br>
      </div>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;"><a name="THECOMPANY"><!--Anchor--></a>THE COMPANY</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">We develop therapeutic products, using cell and tissue protocols, primarily involving adult stem cells. Our two core programs, as described
      below, relate to the treatment of disc/spine disease and metabolic disorders:</div>
    <div style="font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z41d49b677aac48e2b72421835d2c037a" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 3.85%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 3.85%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 92.31%; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Disc/Spine Program (brtxDisc).
              </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">Our lead cell therapy candidate, <font style="font-style: italic;">BRTX-100</font>, is a product formulated from autologous (or a person&#8217;s own) cultured
                mesenchymal stem cells collected from the patient&#8217;s bone marrow. We intend that the product will be used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure. The <font style="font-style: italic;">BRTX-100</font> production process utilizes proprietary technology and involves collecting a patient&#8217;s bone marrow, isolating and culturing stem cells from the bone marrow and cryopreserving the cells. In an
                outpatient procedure, <font style="font-style: italic;">BRTX-100 </font>is to be injected by a physician into the patient&#8217;s damaged disc. The treatment is intended for patients whose pain has not been alleviated by non-surgical procedures
                and who potentially face the prospect of surgery. We have received authorization from the FDA to commence a Phase 2 clinical trial using <font style="font-style: italic;">BRTX-100</font> to treat chronic lower back pain arising from
                degenerative disc disease. We have commenced such clinical trial through the execution of a CRO agreement with PRC Clinical, the execution of clinical trial site agreements, patient enrollment, the commencement of patient procedures, the
                purchase of manufacturing equipment and the expansion of our laboratory to include capabilities for clinical production. In March 2022, a United States patent related to <font style="font-style: italic;">BRTX-100 </font>was issued. We
                have been granted excusive license rights with regard to the patent.</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 3.85%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 3.85%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 92.31%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        </tr>
        <tr>
          <td style="width: 3.85%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;&#160;&#160;</div>
          </td>
          <td style="width: 3.85%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 92.31%; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Metabolic Program (ThermoStem)</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">. We are developing a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue,
                or BAT. We refer to this as our <font style="font-style: italic;">ThermoStem Program</font>. BAT is intended to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans. Initial preclinical research
                indicates that increased amounts of brown fat in animals may be responsible for additional caloric burning as well as reduced glucose and lipid levels. Researchers have found that people with higher levels of brown fat may have a reduced
                risk for obesity and diabetes. Patents related to the <font style="font-style: italic;">ThermoStem Program</font> have been issued in the United States and other jurisdictions.</font></div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a> </div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';"> <br>
    </div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">We have also licensed an investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the
      spine and discs (and other parts of the body). We anticipate that FDA approval or clearance will be necessary for this device prior to commercialization. We do not intend to utilize this device in connection with our Phase 2 clinical trial with
      regard to <font style="font-style: italic;">BRTX-100</font>.</div>
    <div style="font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">The patents and patent applications for the&#160;<font style="font-style: italic;">Disc/Spine Program</font>, the&#160;<font style="font-style: italic;">ThermoStem
        Program</font>&#160;and the curved needle device are listed under &#8220;Business - Technology; Research and Development&#8221; in Part I of our <a href="https://www.sec.gov/Archives/edgar/data/1505497/000149315222008184/0001493152-22-008184-index.htm">Annual
        Report on Form 10-K for the year ended December 31, 2021</a> incorporated herein by reference.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">We are a Nevada corporation. Our headquarters are located
        at 40 Marcus Drive, Suite One, Melville, New York 11747. Our telephone number is (631) 760-8100. We maintain certain information on our website at www.biorestorative.com. The information on our website is not (and should not be considered) part of this prospectus and is not incorporated into this prospectus by reference.</font></div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;"><a name="USEOFPROCEEDS"><!--Anchor--></a>USE OF PROCEEDS</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">Unless we indicate a different use in an accompanying prospectus supplement, the net proceeds from our sale of the offered
      securities will be used for general corporate purposes and working capital, including in connection with our clinical trials with respect to <font style="font-style: italic;">BRTX-100, </font>pre-clinical research and development with respect to
      our <font style="font-style: italic;">ThermoStem Program</font> and other business initiatives.</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">The applicable prospectus supplement will provide more details on the use of proceeds of any specific offering.</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><a name="DESCRIPTIONOFSECURITIESWE"><!--Anchor--></a>DESCRIPTION OF SECURITIES WE MAY OFFER</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">This prospectus contains summary descriptions of the common stock, preferred stock, warrants, debt securities and units that we may offer
      from time to time.&#160; These summary descriptions do not purport to be complete and are subject to, and qualified in their entirety by reference to, the more complete descriptions thereof set forth in our amended and restated articles of incorporation,
      which we refer to as our charter, and our bylaws, each as amended to date. The applicable prospectus supplement may add, update or change the terms and conditions of the securities as described in this prospectus.</div>
    <div style="text-align: justify; text-indent: 22.5pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;"> <a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a></div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;"> <br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">Authorization</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">Our authorized capital stock consists of 95,000,000 shares of capital stock. We are authorized to issue 75,000,000 shares of common stock,
      par value $0.0001 per share, and 20,000,000 shares of preferred stock, par value $0.01 per share.</div>
    <div style="text-align: justify; text-indent: 22.5pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">As of February 6, 2023, there were 3,679,847 shares of common stock issued and outstanding and 1,543,158 shares of Series B preferred stock
      issued and outstanding.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">Common Stock</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Dividend Rights. </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">Subject to preferences that may be applicable to any shares of our preferred stock that may be issued, the holders of our common stock are entitled to share ratably in such
        dividends as may be declared by our Board of Directors out of funds legally available therefor.</font></div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Voting Rights. </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">Each share of our common stock entitles its holder to one vote in the election of directors as well as all other matters to be voted on by stockholders.</font></div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">No Preemptive Rights. </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">Holders of our common stock do not have any preemptive rights to subscribe for additional shares on a pro rata basis or otherwise when additional shares are offered for sale by us.</font></div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Liquidation Rights. </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">Subject to preferences that may be applicable to any shares of our preferred stock that may be issued, in the event of our liquidation, dissolution or winding up, the holders of our
        common stock would be entitled to receive, pro rata, after payment of all of our debts and liabilities, all of our remaining assets available for distribution.</font></div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 22.3pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Other Rights</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">. Holders of our common stock have no preferences or conversion or exchange rights. Shares of our common stock will not be liable for further calls or assessments by us and are not
        subject to redemption.</font></div>
    <div style="text-align: justify; text-indent: 22.5pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">Preferred Stock</div>
    <div style="text-align: justify; text-indent: 22.5pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">Our board of directors has the authority, without further action by our stockholders, to issue from time to time the
      authorized preferred stock in one or more series, and to fix the number of shares, designations, preferences, powers, and other rights and qualifications, limitations or restrictions as our board of directors may authorize, including:</div>
    <table cellspacing="0" cellpadding="0" id="ze6b2d226f1ad464db0054f38f5124e7d" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 10.53%; vertical-align: top;">
            <div style="margin-bottom: 12pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">&#8226;</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 9pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">&#160;</font></div>
          </td>
          <td style="width: 89.47%; vertical-align: top; font-family: 'Times New Roman';">
            <div>the distinctive designation of each series and the number of shares that will constitute the series;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10.53%; vertical-align: top;">
            <div style="margin-bottom: 12pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">&#8226;</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 9pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">&#160;</font></div>
          </td>
          <td style="width: 89.47%; vertical-align: top; font-family: 'Times New Roman';">
            <div>the voting rights, if any, of shares of the series and the terms and conditions of the voting rights;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10.53%; vertical-align: top;">
            <div style="margin-bottom: 12pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">&#8226;</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 9pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">&#160;</font></div>
          </td>
          <td style="width: 89.47%; vertical-align: top; font-family: 'Times New Roman';">
            <div>the dividend rate on the shares of the series, the dates on which dividends are payable, any restriction, limitation or condition upon the payment of dividends, whether dividends will be cumulative, and the dates
              from and after which dividends shall accumulate;</div>
          </td>
        </tr>

    </table>
    <font style="font-family: 'Times New Roman';">
    </font>
    <div><font style="font-family: 'Times New Roman';"><br>
      </font>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">7</font></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber"> <br>
        </font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div><a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a></div>
    <br>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 10.53%; vertical-align: top;">
            <div style="margin-bottom: 12pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">&#8226;</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 9pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">&#160;</font></div>
          </td>
          <td style="width: 89.47%; vertical-align: top; font-family: 'Times New Roman';">
            <div>the prices at which, and the terms and conditions on which, the shares of the series may be redeemed, if the shares are redeemable;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10.53%; vertical-align: top;">
            <div style="margin-bottom: 12pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">&#8226;</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 9pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">&#160;</font></div>
          </td>
          <td style="width: 89.47%; vertical-align: top; font-family: 'Times New Roman';">
            <div>the terms and conditions of a sinking or purchase fund for the purchase or redemption of shares of the series, if such a fund is provided;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10.53%; vertical-align: top;">
            <div style="margin-bottom: 12pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">&#8226;</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 9pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">&#160;</font></div>
          </td>
          <td style="width: 89.47%; vertical-align: top; font-family: 'Times New Roman';">
            <div>any preferential amount payable upon shares of the series in the event of our liquidation, dissolution or winding up, or upon the distribution of any of our assets; and</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10.53%; vertical-align: top;">
            <div style="margin-bottom: 12pt; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">&#8226;</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 9pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">&#160;</font></div>
          </td>
          <td style="width: 89.47%; vertical-align: top; font-family: 'Times New Roman';">
            <div>the prices or rates of conversion or exchange at which, and the terms and conditions on which, the shares of the series may be converted or exchanged into other securities, if the shares are convertible or
              exchangeable.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10.53%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 89.47%; vertical-align: top; font-family: 'Times New Roman';" rowspan="1">&#160;</td>
        </tr>

    </table>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">Depending upon the rights prescribed for a series of preferred stock, the issuance of preferred stock could have an
      adverse effect on the voting power of the holders of common stock and could adversely affect holders of common stock by delaying or preventing a change in control, making removal of our present management more difficult or imposing restrictions upon
      the payment of dividends and other distributions to the holders of common stock.</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">&#160;The particular terms of any series of preferred stock, and the transfer agent and registrar for that series, will be
      described in a prospectus supplement.</div>
    <div style="font-family: 'Times New Roman'; font-weight: bold;">Warrants</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">We may offer to sell warrants from time to time. If we do so, we will describe the specific terms of the warrants in a prospectus supplement.
      In particular, we may issue warrants for the purchase of common stock, preferred stock and/or debt securities in one or more series. We may also issue warrants independently or together with other securities and the warrants may be attached to or
      separate from those securities.</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">We will evidence each series of warrants by warrant certificates that we will issue under a separate agreement. We will enter into the warrant
      agreement with a warrant agent. We will indicate the name and address of the warrant agent in the applicable prospectus supplement relating to a particular series of warrants.</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">We will describe in the applicable prospectus supplement the terms of the series of warrants, including:</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za6639aabe0d9412984e3e99be3c5f150" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the offering price and aggregate number of warrants offered;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z53b7ce1a2266420f952ee3a72972f5c6" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the currency for which the warrants may be purchased;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zda69e4a2b8bf4b8ab4bb709d0aaf73d7" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such
              security;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">8</font></div>
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber"> <br>
        </font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z69754e5d34454c7fa8e3e6102c30657b" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">if applicable, the date on and after which the warrants and the related securities will be separately transferable;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zdb8d3e06fb5d4fe09d5fb2537bc85d2c" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">in the case of warrants to purchase debt securities, the principal amount of debt securities purchasable upon exercise of one warrant and the price at, and currency in which, this principal
              amount of debt securities may be purchased upon such exercise;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z958b12ff136c43e4964467e3a2cc738c" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">in the case of warrants to purchase common stock or preferred stock, the number of shares of common stock or preferred stock, as the case may be, purchasable upon the exercise of one warrant
              and the price at which these shares may be purchased upon such exercise;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z75051181e6a64b2e98746c733d4589bd" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreement and the warrants;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5cc9472c37384637a51d208c344a1192" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the terms of any rights to redeem or call the warrants;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z3f2ad124b9894dfba7ce69dbe6ddabca" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top;">
            <div style="margin-left: 27.25pt; font-family: 'Times New Roman';">any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants;</div>
            <div style="font-family: 'Times New Roman';">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the dates on which the right to exercise the warrants will commence and expire;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        </tr>
        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the manner in which the warrant agreement and warrants may be modified;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        </tr>
        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">certain United States federal income tax consequences of holding or exercising the warrants;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        </tr>
        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-indent: 27.3pt;">the terms of the securities issuable upon exercise of the warrants; and</div>
          </td>
        </tr>
        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        </tr>
        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">any other specific material terms, preferences, rights or limitations of or restrictions on the warrants.</div>
          </td>
        </tr>

    </table>
    <div style="font-family: 'Times New Roman';">
      <div style="margin-top: 12pt; margin-bottom: 12pt; font-weight: bold;">Debt Securities</div>
    </div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">The following is a description of the material features, terms and provisions of debt securities that we may offer. This summary does not
      purport to be exhaustive and may not contain all the information that is important to you. Therefore, you should read the applicable prospectus supplement relating to those debt securities and any other offering materials that we may provide.</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">We may issue debt securities from time to time in one or more series. We may issue senior debt securities or subordinated debt securities under
      separate indentures, which may be supplemented or amended from time to time. Senior debt securities would be issued under a senior indenture and subordinated debt securities would be issued under a subordinated indenture. The senior debt indenture
      and subordinated debt indenture are referred to individually in this prospectus as the indenture, and collectively as the indentures.</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">9</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;"> <a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a></div>
    <div style="font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">The particular terms of a series of debt securities will be described in a prospectus supplement relating to such series of debt securities.
      The indentures will be subject to and governed by the Trust Indenture Act of 1939, as amended, and may be supplemented or amended from time to time following their execution. Unless otherwise stated in the applicable prospectus supplement, we will
      not be limited in the amount of debt securities that we may issue and neither the senior debt securities nor the subordinated debt securities will be secured by any of our property or assets. Thus, by owning debt securities, you are one of our
      unsecured creditors.</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">&#160;&#160;</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">The indentures, and any supplemental indentures, will contain the full legal text of the matters described in this section of the prospectus.
      Because this section is a summary, it does not describe every aspect of the debt securities or any applicable indentures or supplemental indenture. This summary is therefore subject to and is qualified in its entirety by reference to all the
      provisions of any applicable indenture or supplemental indenture, including any definitions of terms used in such indenture. Your rights will be defined by the terms of any applicable indenture or supplemental indenture, not the summary provided
      herein. This summary is also subject to and qualified by reference to the description of the particular terms of a particular series of debt securities described in the applicable prospectus supplement or supplements.</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">The debt securities may be denominated and payable in U.S. dollars. We may also issue debt securities, from time to time, with the principal
      amount, interest or other amounts payable on any relevant payment date to be determined by reference to one or more currency exchange rates, securities or baskets of securities, commodity prices, indices or any other financial, economic or other
      measure or instrument, including the occurrence or non-occurrence of any event or circumstance. In addition, we may issue debt securities as part of any units issued by us. All references in this prospectus or any prospectus supplement to other
      amounts will include premiums, if any, other cash amounts payable under the applicable indenture, and the delivery of securities or baskets of securities under the terms of the debt securities. Debt securities may bear interest at a fixed rate, which
      may be zero, or a floating rate.</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">We will set forth in the applicable prospectus supplement the terms, if any, on which a series of debt securities may be convertible into or
      exchangeable for our preferred stock, common stock or other securities. We will include provisions as to whether conversion or exchange is mandatory, at the option of the holder or at our option. We may include provisions pursuant to which the number
      of shares of our preferred stock, common stock or other securities that holders of the series of debt securities receive would be subject to adjustment.</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">The applicable prospectus supplement will describe the debt securities and the price or prices at which we will offer the debt securities. The
      description will, to the extent applicable, include:</div>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z0378ef68b32242bc82c54f475982393e" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the title and form of the debt securities;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7627f7479fe14eb39b8ebf0ba49393e9" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the ranking of the debt securities as compared to other debt;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z4bb499206b984f9eb7da3a60bbc96a8f" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the aggregate principal amount of the debt securities or the series of which they are a part;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">10</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div><a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a></div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zf4690c2b0d654e7983be9c2dba405789" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the person or persons to whom any principal or interest on a debt security of the series will be paid;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z55f1a501424c4a6dbf55c62c14296659" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the date or dates on which we must repay the principal;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zbf15ae73b1874323a1d024153ef3ff0c" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the rate or rates at which the debt securities will bear interest;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zf70a00f5d0ed4aa7829d6c5c8430f6d8" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the date or dates from which interest will accrue, and the dates on which we must pay interest;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zfe39fb8cd3e3406eac899f67dab9868a" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the place or places where we must pay the principal and any premium or interest on the debt securities;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z655ed425b4db4bac8cae6e84c9908110" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the terms and conditions on which the debt securities may be convertible into other securities;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5236a0dd79134eb49bdbf8fb36ffcbfd" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">whether the debt securities are entitled to the benefit of any sinking fund;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7df1cb467be541a183253f0d08b8f5f2" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the identity of the trustee;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z3aa9f79f4c1440558d65702c1da84f9d" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the terms and conditions on which we may redeem any debt security, if at all;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z0e10d5334ac84c8688bda4adb7e132ac" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">any obligation to redeem or purchase any debt securities, and the terms and conditions on which we must do so;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zd0508c4bed2d4b55995125e881506ff3" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the denominations in which we may issue the debt securities;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za1733801486b4f61bd7a14ed3b76e1d5" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the manner in which we will determine the amount of principal of or any premium or interest on the debt securities;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5d0126a0cfad4015b13f4600e4584fd0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the currency in which we will pay the principal of and any premium or interest on the debt securities;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zcb7431204c1a4d6092c31fc011bcc7dd" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the principal amount of the debt securities that we will pay upon declaration of acceleration of their maturity;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z66c94b0537384ea2bd23cedbd5835523" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">the amount that will be deemed to be the principal amount for any purpose, including the principal amount that will be due and payable upon any maturity or that will be deemed to be
              outstanding as of any date;</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za69df4a37cec476093a052d43448fe18" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">whether the debt securities are defeasible and the terms of such defeasance; and</div>
          </td>
        </tr>

    </table>
    <div style="margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z77cbc435e4464aec8192c2a74f8736e1" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 8.6%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 36pt; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.4%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 27.25pt;">any addition to or change in the events of default applicable to the debt securities and any change in the right of the trustee or the holders to declare the principal amount of any of the
              debt securities due and payable.</div>
          </td>
        </tr>

    </table>
    <div style="font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">Some of the debt securities may be issued as original issue discount debt securities. Original issue discount securities bear no interest or
      bear interest at below market rates and will be sold at a discount below their stated principal amount. A prospectus supplement relating to an issue of original issue discount securities will contain information relating to United States federal
      income tax, accounting, and other special considerations applicable to original issue discount securities.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">11</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;"> <a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a></div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;"> <br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">Units</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">We may issue units comprised of one or more of the other securities described in this prospectus or any prospectus supplement in any
      combination. Each unit will be issued so that the holder of the unit is also the holder, with the rights and obligations of a holder, of each security included in the unit. The unit agreement under which a unit is issued may provide that the
      securities included in the unit may not be held or transferred separately, at any time or at any times before a specified date or upon the occurrence of a specified event or occurrence.</div>
    <div style="text-align: justify; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman';">The applicable prospectus supplement will describe:</div>
    <div style="text-align: justify; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z3b29d86a018946b38d8d24e0ac970dcc" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 2.52%; vertical-align: middle; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 6.14%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.34%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 31.2pt;">the designation and the terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.52%; vertical-align: middle; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 6.14%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: right;">&#160;</div>
          </td>
          <td style="width: 91.34%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 31.2pt;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.52%; vertical-align: middle; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 6.14%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.34%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 31.2pt;">any unit agreement under which the units will be issued;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.52%; vertical-align: middle; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 6.14%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: right;">&#160;</div>
          </td>
          <td style="width: 91.34%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 31.2pt;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.52%; vertical-align: middle; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 6.14%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.34%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 31.2pt;">any provisions for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units; and</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.52%; vertical-align: middle; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 6.14%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: right;">&#160;</div>
          </td>
          <td style="width: 91.34%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 31.2pt;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.52%; vertical-align: middle; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 6.14%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; font-weight: bold;">&#8226;</div>
          </td>
          <td style="width: 91.34%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 31.2pt;">whether the units will be issued in fully registered or global form.</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">Certain Provisions Having Potential Anti-Takeover Effects</div>
    <div style="text-align: justify; text-indent: 22.5pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</div>
    <div style="text-indent: 22.3pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">General. </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">The following is a summary of the material provisions of the Nevada Revised Statues, which we refer to as the NRS, and our charter and bylaws that address matters of corporate
        governance and the rights of stockholders. Certain of these provisions may delay or prevent takeover attempts not first approved by our Board of Directors (including takeovers which certain stockholders may deem to be in their best interests).
        These provisions also could delay or frustrate the removal of incumbent directors or the assumption of control by stockholders. The primary purpose of these provisions is to encourage negotiations with our management by persons interested in
        acquiring control of our company. All references to the charter and bylaws are to our charter and bylaws in effect on the date of this prospectus.</font></div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div>
      <div style="text-indent: 20pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Combinations with Interested
          Stockholder.&#160;&#160;&#160;</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">Sections&#160;78.411-78.444, inclusive, of the NRS contain provisions governing combinations with an interested stockholder. For purposes of the NRS,
          &#8220;combinations&#8221; include: (i)&#160;any merger or consolidation with any interested stockholder, (ii)&#160;any sale, lease, exchange, mortgage, pledge, transfer or other disposition to any interested stockholder of corporate assets with an aggregate market
          value equal to more than 5% of the aggregate market value of the corporation&#8217;s consolidated assets, more than 5% of the aggregate market value of outstanding shares of the corporation or more than 10% of the earning power or net income of the
          corporation, (iii)&#160;the issuance to any interested stockholder of voting shares (except pursuant to a share dividend or similar proportionate distribution) with an aggregate market value equal to 5% or more of the aggregate market value of all the
          outstanding shares of the corporation, (iv)&#160;the adoption of the dissolution of the corporation if proposed by or on behalf of any interested stockholder, (v)&#160;any reclassification of securities, recapitalization or corporate reorganization that
          will have the effect of increasing the proportionate share of the corporation&#8217;s outstanding voting shares held by any interested stockholder and (vi)&#160;any receipt by the interested stockholder of the benefit (except proportionately as a
          stockholder) of any loan, advance, guarantee, pledge or other financial assistance. For purposes of the NRS, an &#8220;interested stockholder&#8221; is defined to include any beneficial owner of more than 10% of any class of the voting securities of a Nevada
          corporation and any person who is an affiliate or associate of the corporation and was at any time during the preceding two&#160;years the beneficial owner of more than 10% of any class of the voting securities of the Nevada corporation.</font></div>
    </div>
    <div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
      </div>
      <div style="font-family: 'Times New Roman',Times,serif;"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a> </div>
      <div style="text-indent: 20pt; font-family: 'Times New Roman';"> <br>
      </div>
      <div style="text-indent: 20pt; font-family: 'Times New Roman';">Subject to certain exceptions, the provisions of the NRS statute governing combinations with interested stockholders provide that a Nevada
        corporation may not engage in a combination with an interested stockholder for two&#160;years after the date that the person first became an interested stockholder unless the combination or the transaction by which the person first became an interested
        stockholder is approved by the Board of Directors before the person first became an interested stockholder, or unless the combination is approved by the Board of Directors and sixty&#160;percent of the corporation&#8217;s voting power not beneficially owned
        by the interested stockholder, its affiliates and associates.</div>
    </div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">&#160;Control Share Acquisitions.</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;&#160;The NRS also contains a &#8220;control share acquisitions statute.&#8221; If
        applicable to a Nevada corporation this statute restricts the voting rights of certain stockholders referred to as &#8220;acquiring persons,&#8221; that acquire or offer to acquire ownership of a &#8220;controlling interest&#8221; in the outstanding voting stock of an
        &#8220;issuing corporation.&#8221; For purposes of these provisions, a &#8220;controlling interest&#8221; means with certain exceptions the ownership of outstanding voting stock sufficient to enable the acquiring person to exercise one-fifth or more but less than&#160;one-third,&#160;one-third&#160;or more but less than a majority, or a majority or more of all voting power in the election of directors; &#8220;issuing corporation&#8221; means a Nevada corporation that has 200 or more stockholders of record, at least 100 of whom have
        addresses in Nevada appearing on the stock ledger of the corporation at all times during the 90&#160;days immediately preceding such date, and which does business in Nevada directly or through an affiliated corporation. The voting rights of an acquiring
        person in the affected shares will be restored only if such restoration is approved by the holders of a majority of the voting power of the corporation. The NRS allows a corporation to &#8220;opt-out&#8221; of the control share acquisitions statute by
        providing in such corporation&#8217;s articles of incorporation or bylaws that the control share acquisitions statute does not apply to the corporation or to an acquisition of a controlling interest specifically by types of existing or future
        stockholders, whether or not identified. The Company has not opted out of this statute.</font></div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Authorized But Unissued Shares. </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">Nevada law does not require stockholder approval for any issuance of authorized shares. Authorized but unissued shares may be used for a variety of corporate purposes, including
        future public or private offerings to raise additional capital or to facilitate corporate acquisitions. One of the effects of the existence of authorized but unissued shares may be to enable our Board of Directors to issue shares to persons
        friendly to current management, which issuance could render more difficult or discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise, and thereby protect the continuity of our management and
        possibly deprive the stockholders of opportunities to sell their shares of common stock at prices higher than prevailing market prices.</font></div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">13</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a> </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"> <br>
      </font></div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Preferred Stock</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">. Under the terms of our charter, our Board of Directors is authorized to issue shares of preferred stock in one or more series without stockholder approval. Our Board of Directors
        has the discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series of preferred stock. The purpose of
        authorizing our Board of Directors to issue preferred stock and determine its rights and preferences is to provide flexibility and eliminate delays associated with a stockholder vote on specific issues. However, the ability of our Board of
        Directors to issue preferred stock and determine its rights and preferences may have the effect of delaying or preventing a change in control, as described above under &#8220;Description of Securities We May Offer &#8212; Preferred Stock.&#8221;</font></div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Classified Board. </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">We have a classified Board of Directors consisting of three classes of directors. A classified board is one in which a certain number, but not all, of the directors are elected on a
        rotating basis each year. This method of electing directors makes changes in the composition of our Board more difficult, and thus a potential change in control may be a lengthier process. The existence of our classified Board reduces the
        possibility that a third party could effect an unsolicited change in control of our Board. Since our classified Board will increase the amount of time required for a takeover bidder to obtain control of us without the cooperation of the Board, even
        if the takeover bidder were to acquire a majority of our outstanding common stock, the existence of our classified Board could tend to discourage certain tender offers which stockholders might feel would be in their best interests. Our classified
        Board will likely allow management, if confronted by a proposal from a third party who has acquired a block of our common stock, sufficient time to review the proposal and appropriate alternatives to the proposal and to attempt to negotiate a
        better transaction, if possible, for our stockholders.</font></div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Special Meetings of Stockholders.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"> Our bylaws provide that special meetings of stockholders may be called only by our Board of Directors or the Chairman of the Board.</font></div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">&#160;<font style="font-style: italic;">&#160;</font></div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Filling Vacancies.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"> Vacancies occurring in our Board of Directors and newly created directorships resulting from an increase in the authorized number of directors may be filled by a majority of the
        remaining directors, even if less than a quorum.</font></div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Removal of Directors by
        Stockholders. </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">Under the terms of our charter, stockholders may remove directors with or without cause with the affirmative vote of holders of 75% of the voting power
        of all of the then-outstanding shares of our capital stock then entitled to vote at an election of directors, voting together as a single class.</font></div>
    <div style="font-family: 'Times New Roman'; font-style: italic;">&#160;</div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Amendment of Bylaws.</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"> Our bylaws may be amended by our Board of Directors or by the holders of at least 75% of the voting power of our company.</font></div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Amendment of Certain Charter
        Provisions. </font><font style="font-family: 'Times New Roman'; font-size: 10pt;">Under the terms of our charter, amending certain charter provisions requires the affirmative vote of the holders of at least 75% of the voting power of all
        of the then-outstanding shares of our capital stock entitled to vote thereon, voting together as a single class. The provisions subject to such heightened requirement include those relating to stockholder action by written consent, the calling of
        special meetings, board classification, the filling of board vacancies, the removal of directors and the ability to amend our bylaws, among others.</font></div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">14</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a> </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"> <br>
      </font></div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Advance Notification of Stockholder
        Nominations and Proposals</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">. Our bylaws establish advance notice procedures with respect to the nomination of persons for election as directors, other than nominations
        made by or at the direction of our Board of Directors, and stockholder proposals for business.</font></div>
    <div style="text-align: justify; text-indent: 22.5pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 22.3pt; font-family: 'Times New Roman'; font-style: italic;">Stockholder Nominees; Stockholder Proposals.</div>
    <div style="text-align: justify; text-indent: 22.5pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 22.3pt; font-family: 'Times New Roman';">In order for a stockholder to nominate a candidate for director at, or bring any business before, an annual meeting of stockholders, under
      our bylaws, timely notice of the nomination or business must be received by us in advance of the meeting. To be timely, a stockholder&#8217;s notice must be delivered to or mailed and received by our Secretary at our principal executive offices not less
      than 90 days nor more than 120 days prior to the one-year anniversary of the date on which we first mailed the proxy materials for the preceding year&#8217;s annual meeting of stockholders; provided, however, that if the meeting is convened more than 30
      days prior to or delayed more than 60 days after the anniversary of the preceding year&#8217;s annual meeting, to be timely a stockholder&#8217;s notice must be received not earlier than the close of business on the 120th day prior to the date of such annual
      meeting and not later than the close of business on the later of the 90th day prior to the date of such annual meeting or, if the first public announcement of the date of such annual meeting is less than 100 days prior to the date of such annual
      meeting, the 10th day following the day on which public announcement of the date of such meeting is first made by us.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 22.3pt; font-family: 'Times New Roman';">The stockholder sending the notice of nomination or proposed business must describe various matters, including the following:</div>
    <div style="text-indent: -13.5pt; margin-left: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z1149cacbe4324ed9b08d8bf5addd1139" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 4.62%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 3.85%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 91.54%; vertical-align: top; font-family: 'Times New Roman';">
            <div>as to each person whom the stockholder proposes to nominate for election as a director, all information relating to such person as would be required to be disclosed in solicitations of proxies for election of such
              nominee as a director pursuant to Regulation 14A under the Exchange Act;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4.62%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 3.85%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 91.54%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 4.62%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 3.85%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#9679;</div>
          </td>
          <td style="width: 91.54%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;(i) the name and address of such stockholder, as they appear on our books and of such beneficial owner or Control Person (as defined in our bylaws), if any, (ii) the number of our shares which are, directly or
              indirectly, owned beneficially and of record by such stockholder and such beneficial owner or Control Person, if any (iii) a representation that the stockholder intends to appear at the meeting in person or by proxy to submit the business
              specified in such notice, (iv) if the notice relates to any business other than a nomination of director(s), a brief description of the business desired to be brought before the meeting, including the complete text of any resolutions proposed
              for consideration, and the reasons for conducting such business at the meeting, (v) any direct or indirect personal or other interest of the stockholder in the business to be submitted, (vi) a description of any agreement, arrangement or
              understanding (including any derivative or short positions, profit interests, options, hedging transactions, and borrowed or loaned shares) that has been entered into as of the date of the stockholder&#8217;s notice by, or on behalf of, such
              stockholder or beneficial owner and by any Control Person or any other person acting in concert with any of the foregoing, the effect or intent of which is to mitigate loss, manage risk or benefit from changes in the share price of any class
              of our stock, or maintain, increase or decrease the voting power of the stockholder or beneficial owner with respect to shares of our stock, and a representation that the stockholder will notify us in writing within five business days after
              the record date for such meeting of any such agreement, arrangement or understanding in effect as of the record date for the meeting, (vii) a representation whether the stockholder or the beneficial owner, if any, and any Control Person will
              engage in a solicitation with respect to the nomination or business and, if so, the name of each participant (as defined in Item 4 of Schedule 14A under the Securities Exchange Act of 1934) in such solicitation and whether such person intends
              or is part of a group which intends to deliver a proxy statement and/or form of proxy to holders of at least the percentage of our outstanding stock required to approve or adopt the business to be proposed (in person or by proxy) by the
              stockholder and (viii) any other information relating to such stockholder, beneficial owner or Control Person, if any, that would be required to be disclosed in a proxy statement and form of proxy or other filings required to be made in
              connection with solicitations of proxies for, as applicable, the proposal and/or for the election of directors in a contested election pursuant to Section 14 of the Securities Exchange Act of 1934 and the rules and regulations promulgated
              thereunder.</div>
          </td>
        </tr>

    </table>
    <div style="text-indent: 22.3pt; font-family: 'Times New Roman'; font-style: italic;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">15</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a> </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';"> <br>
    </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">These provisions are intended to enhance the likelihood of continuity and stability in the composition of the Board and in policies
      formulated by the Board and to discourage certain types of transactions that may involve an actual or threatened change of control of our company. These provisions are designed to reduce our vulnerability to an unsolicited proposal for a takeover
      that does not contemplate the acquisition of all of our outstanding shares or an unsolicited proposal for the restructuring or sale of all or part of our company.</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">Limitations on Director Liability</div>
    <div style="text-align: justify; text-indent: 22.5pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">Our charter provides that our directors shall generally not be liable to us or any of our stockholders for damages for breach of duty as a
      director. This provision will eliminate such liability except for (i) any breach of the director&#8217;s duty of loyalty to us or to our stockholders, (ii) acts and omissions not in good faith or which involve intentional misconduct or a knowing violation
      of law, (iii) liability for unlawful payment of dividends or unlawful stock purchases or redemptions in violation of the NRS, and (iv) any transaction from which the director derived an improper personal benefit.</div>
    <div style="text-align: justify; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">Indemnification of Directors and Officers</div>
    <div style="text-align: justify; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">Section 78.7502(1) of the NRS provides that a corporation may, and our charter and bylaws provide that we shall, indemnify any person who was
      or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, or an Action, by reason of the fact that he is or was our director,
      officer, employee or agent or is or was serving at our request in such capacity in another corporation, partnership, joint venture, trust or other enterprise, or the Indemnified Party, against expenses (including attorney&#8217;s fees), judgments, fines
      and amounts paid in settlement actually and reasonably incurred by him in connection with such action, suit or proceeding if he acted in good faith and in a manner he reasonably believed to be in or not opposed to our best interests, and, with
      respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful; provided, however, no indemnification shall be made in respect of any Actions by or in our right if the Indemnified Party shall have been
      adjudged by a court of competent jurisdiction, after exhaustion of any appeals, to be liable to us, unless and only to the extent that the court shall determine that, despite the adjudication of liability but in view of all circumstances, such person
      is fairly and reasonably entitled to indemnity.&#160;&#160;</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">16</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a> </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';"> <br>
    </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">Under the NRS, the directors have a fiduciary duty to us that is not eliminated by this provision of our charter and, in appropriate
      circumstances, equitable remedies such as injunctive or other forms of non-monetary relief will remain available.&#160;&#160;In addition, each director will continue to be subject to liability under the NRS for breach of the director&#8217;s duty of loyalty to us
      for acts or omissions which are found by a court of competent jurisdiction to not be in good faith or involve intentional misconduct, for knowing violations of law, for actions leading to improper personal benefit to the director, and for payment of
      dividends or approval of stock repurchases or redemptions that are prohibited by the NRS. This provision also does not affect the directors&#8217; responsibilities under any other laws, such as the federal securities laws or state or federal environmental
      laws.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">Furthermore, Section 78.7502(3) of the NRS provides that determination of an Indemnified Party&#8217;s eligibility for indemnification by us shall
      be made on a case-by-case basis by: (i) the stockholders; (ii) the board of directors by a majority vote of a quorum consisting of directors who were not parties to the action, suit or proceeding; (iii) independent legal counsel&#8217;s written opinion if:
      (1) a majority vote of a quorum consisting of directors who were not parties to the action, suit or proceeding so orders; or (2) a quorum consisting of directors who were not parties to the action, suit or proceeding cannot be obtained.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">Lastly, Section 78.752(1) of the NRS empowers a corporation to purchase and maintain insurance or make other financial arrangements with
      respect to liability arising out of the actions or omissions of directors, officers, employees or agents in their capacity or status as such, whether or not the corporation has the authority to indemnify him against such liability.&#160;&#160;</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">Our charter provides that, to the fullest extent permitted by the NRS, no director or officer shall be personally liable to us or to our
      stockholders for monetary damages for breach of fiduciary duty as a director or an officer, except to the extent that such exemption from liability or limitation thereof is not permitted under the NRS currently in effect or as the same may be
      amended.&#160; If the NRS is amended to further eliminate or limit or authorize corporate action to further eliminate or limit the liability of directors or officers, the liability of our directors and officers shall be eliminated or limited to the
      fullest extent permitted by the NRS, as so amended from time to time.&#160; No repeal or modification of this provision of our charter will apply to or have any effect on the liability or alleged liability of any of our directors or officers for or with
      respect to any acts or omissions of such directors or officers occurring prior to such repeal or modification.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">Our bylaws provide that we will indemnify and hold harmless any person who was or is a party or is threatened to be made a party to any
      threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, in such manner, under such circumstances and to the fullest extent permitted by our charter and the NRS.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">17</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a> </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';"> <br>
    </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling
      persons under the provisions discussed above or otherwise, we have been advised that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#160;</font><font style="font-family: 'Times New Roman';">&#160;</font></div>
    <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">Transfer Agent</div>
    <div style="text-align: justify; text-indent: 22.5pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 22.5pt; font-family: 'Times New Roman';">The transfer agent for our common stock is Transhare Corporation.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;"><a name="PLANOFDISTRIBUTION"><!--Anchor--></a>PLAN OF DISTRIBUTION</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">We may use this prospectus, any applicable prospectus supplement and any related free writing prospectus that we authorize
      for use in connection with this offering to sell our securities from time to time pursuant to underwritten public offerings, negotiated transactions, block trades or a combination of these methods. We may sell our securities (1) through one or more
      underwriters or dealers, (2) through one or more agents, and/or (3) directly to one or more purchasers. We may distribute our securities from time to time in one or more transactions at:</div>
    <table cellspacing="0" cellpadding="0" id="z9ba1af2cd92d43969c49dc741caca870" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 18.03%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; text-indent: -0.65pt; margin-left: 35.25pt;">&#8226;</div>
          </td>
          <td style="width: 81.97%; vertical-align: top; font-family: 'Times New Roman';">
            <div>a fixed price or prices, which may be changed;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 18.03%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; text-indent: -0.65pt; margin-left: 35.25pt;">&#8226;</div>
          </td>
          <td style="width: 81.97%; vertical-align: top; font-family: 'Times New Roman';">
            <div>market prices prevailing at the time of sale;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 18.03%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; text-indent: -0.65pt; margin-left: 35.25pt;">&#8226;</div>
          </td>
          <td style="width: 81.97%; vertical-align: top; font-family: 'Times New Roman';">
            <div>prices related to the prevailing market prices;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 18.03%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; text-indent: -0.65pt; margin-left: 35.25pt;">&#8226;</div>
          </td>
          <td style="width: 81.97%; vertical-align: top; font-family: 'Times New Roman';">
            <div>varying prices determined at the time of sale; or</div>
          </td>
        </tr>
        <tr>
          <td style="width: 18.03%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; text-indent: -0.65pt; margin-left: 35.25pt;">&#8226;</div>
          </td>
          <td style="width: 81.97%; vertical-align: top; font-family: 'Times New Roman';">
            <div>negotiated prices.</div>
          </td>
        </tr>

    </table>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">We may solicit directly offers to purchase the securities being offered by this prospectus. We may also designate agents
      to solicit offers to purchase our securities from time to time. We will name in a prospectus supplement any underwriter, dealer or agent involved in the offer or sale of our securities and describe any commissions payable by us to these agents in the
      applicable prospectus supplement. Unless otherwise indicated in the applicable prospectus supplement, these agents will be acting on a best efforts basis for the period of their appointment. The agents may be customers of, or may engage in
      transactions with or perform services for, us in the ordinary course of business.</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">We may also sell equity securities covered by this registration statement in an &#8220;at the market&#8221; offering as defined in Rule 415(a)(4) under the
      Securities Act. Such offering may be made into an existing trading market for such securities in transactions at other than a fixed price on or through the facilities of the Nasdaq Capital Market or any other securities exchange or quotation or
      trading service on which such securities may be listed, quoted or traded at the time of sale. Such at the market offerings, if any, may be conducted by underwriters acting as principal or agent.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">If we utilize a dealer in the sale of the securities being offered by this prospectus, we will sell our securities to the
      dealer, as principal. The dealer may then resell our securities to the public at varying prices to be determined by the dealer at the time of resale.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">18</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a>
      <div><br>
      </div>
    </div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">If we utilize an underwriter in the sale of our securities being offered by this prospectus, we will execute an
      underwriting agreement with the underwriter at the time of sale and we will provide the name of any underwriter in the prospectus supplement which the underwriter will use to make resales of our securities to the public. In connection with the sale
      of our securities, we, or the purchasers of our securities for whom the underwriter may act as agent, may compensate the underwriter in the form of underwriting discounts or commissions. The underwriter may sell our securities to or through dealers,
      and the underwriter may compensate those dealers in the form of discounts, concessions or commissions.</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">With respect to underwritten public offerings, negotiated transactions and block trades, we will provide in the applicable
      prospectus supplement any compensation we pay to underwriters, dealers or agents in connection with the offering of our securities, and any discounts, concessions or commissions allowed by underwriters to participating dealers. Underwriters, dealers
      and agents participating in the distribution of our securities may be deemed to be underwriters within the meaning of the Securities Act and any discounts and commissions received by them and any profit realized by them on resale of our securities
      may be deemed to be underwriting discounts and commissions. We may enter into agreements to indemnify underwriters, dealers and agents against civil liabilities, including liabilities under the Securities Act, or to contribute to payments they may be
      required to make in respect thereof.</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">Our common stock is listed for trading on the Nasdaq Capital Market.&#160; We may elect to list any other security we offer on an exchange, but we
      are not obligated to do so.&#160; To facilitate the offering of our securities, certain persons participating in the offering may engage in transactions that stabilize, maintain or otherwise affect the price of our securities. This may include
      over-allotments or short sales of our securities, which involve the sale by persons participating in the offering of more securities than we sold to them. In these circumstances, these persons would cover such over-allotments or short positions by
      making purchases in the open market or by exercising their over-allotment option. In addition, these persons may stabilize or maintain the price of our securities by bidding for or purchasing our securities in the open market or by imposing penalty
      bids, whereby selling concessions allowed to dealers participating in the offering may be reclaimed if securities sold by them are repurchased in connection with stabilization transactions. The effect of these transactions may be to stabilize or
      maintain the market price of our securities at a level above that which might otherwise prevail in the open market.&#160; These transactions may be discontinued at any time.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">The underwriters, dealers and agents may engage in other transactions with us, or perform other services for us, in the
      ordinary course of their business.</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">In order to comply with the securities laws of certain states, if applicable, the securities offered by this prospectus
      may be sold in these jurisdictions only through registered or licensed brokers or dealers.&#160; In addition, in certain states, the securities offered by this prospectus may not be sold unless such securities have been registered or qualified for sale in
      these states or an exemption from registration or qualification is available.</div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;"><a name="LEGALMATTERS"><!--Anchor--></a>LEGAL MATTERS</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">Except as otherwise provided in any prospectus supplement, the validity of the issuance of the securities to be offered by
      this prospectus will be passed upon for us by Certilman Balin Adler &amp; Hyman, LLP, East Meadow, New York. As of February 6, 2023, members of Certilman Balin Adler &amp; Hyman, LLP owned 41 shares of our common stock. If legal matters in connection
      with offerings made pursuant to this prospectus are passed upon by counsel for underwriters, dealers or agents, if any, such counsel will be named in the prospectus supplement relating to such offering.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">19</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;"><a name="EXPERTS"><!--Anchor--></a></div>
    <div style="font-family: 'Times New Roman',Times,serif; font-weight: 400;"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a> </div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;">EXPERTS</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">Our consolidated financial statements as of December&#160;31, 2021 and 2020 and for the years then ended appearing in our
      Annual Report on Form 10-K for the year ended December 31, 2021 have been incorporated by reference in this prospectus in reliance upon the report of Friedman LLP, an independent registered public accounting firm, incorporated by reference herein,
      and upon the authority of said firm as experts in accounting and auditing.</div>
    <div style="margin-bottom: 12pt; font-family: 'Times New Roman';"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">20</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div><font style="font-family: 'Times New Roman'; font-weight: bold;"> </font><br>
      <a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a></div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: center; margin-top: 27pt; font-family: 'Times New Roman'; font-weight: bold;">BIORESTORATIVE THERAPIES, INC.</div>
    <div style="margin-top: 27pt; font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: center; margin-bottom: 6pt; font-family: 'Times New Roman'; font-weight: bold;">$75,000,000</div>
    <div style="text-align: center; margin-bottom: 6pt; font-family: 'Times New Roman'; font-weight: bold;">Common Stock</div>
    <div style="text-align: center; margin-bottom: 6pt; font-family: 'Times New Roman'; font-weight: bold;">Preferred Stock</div>
    <div style="text-align: center; margin-bottom: 6pt; font-family: 'Times New Roman'; font-weight: bold;">Warrants</div>
    <div style="text-align: center; margin-bottom: 6pt; font-family: 'Times New Roman'; font-weight: bold;">Debt Securities</div>
    <div style="text-align: center; margin-bottom: 6pt; font-family: 'Times New Roman'; font-weight: bold;">Units</div>
    <div style="margin-top: 27pt; font-family: 'Times New Roman';"><br>
    </div>
    <div style="font-family: 'Times New Roman';">&#160;</div>
    <div>
      <div style="text-align: center; margin-bottom: 1.5pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
    </div>
    <div style="text-align: center; margin-top: 13.5pt; font-family: 'Times New Roman'; font-weight: bold;">PROSPECTUS</div>
    <div>
      <div style="text-align: center; margin-bottom: 1.5pt; font-family: 'Times New Roman';">&#160;</div>
      <div style="font-family: 'Times New Roman';"><br>
      </div>
    </div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-align: center; margin-top: 54pt; font-family: 'Times New Roman'; font-weight: bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2023</div>
    <div style="margin-bottom: 12pt; font-family: 'Times New Roman';"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%II-%%-->
    <div style="margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;"> <a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a></div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;">PART II</div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;">INFORMATION NOT REQUIRED IN PROSPECTUS</div>
    <table cellspacing="0" cellpadding="0" id="z08cf987afa734d3e8787a1ed06994504" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="font-weight: bold;">&#160;Item&#160;14.</div>
          </td>
          <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="font-weight: bold;">Other Expenses of Issuance and Distribution.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman';" rowspan="1">&#160;</td>
          <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman';" rowspan="1">&#160;</td>
        </tr>

    </table>
    <div style="text-indent: 24.5pt; margin-bottom: 12pt; font-family: 'Times New Roman';">The following table sets forth the costs and expenses to be incurred by the Registrant in connection with the issuance
      and distribution of the securities being offered hereby.&#160;&#160; With the exception of the Securities and Exchange Commission registration fee, all fees and expenses set forth below are estimates.</div>
    <table cellspacing="0" cellpadding="0" id="z8dd24e6069294e8795afb7a93d56839a" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 79%; vertical-align: top; font-family: 'Times New Roman';" colspan="2">&#160;</td>
          <td style="width: 21%; vertical-align: top; border-bottom: 2px solid black; font-family: 'Times New Roman';">
            <div style="text-align: center; font-weight: bold;">Amount</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79%; vertical-align: top; font-family: 'Times New Roman';" colspan="2">
            <div style="text-align: justify;">Securities and Exchange Commission registration fee</div>
          </td>
          <td style="width: 21%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">$8,265.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79%; vertical-align: top; font-family: 'Times New Roman';" colspan="2">
            <div style="text-align: justify;">Accounting fees and expenses</div>
          </td>
          <td style="width: 21%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79%; vertical-align: top; font-family: 'Times New Roman';" colspan="2">
            <div style="text-align: justify;">Legal fees and expenses</div>
          </td>
          <td style="width: 21%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79%; vertical-align: top; font-family: 'Times New Roman';" colspan="2">
            <div style="text-align: justify;">Printing expenses</div>
          </td>
          <td style="width: 21%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 79%; vertical-align: top; font-family: 'Times New Roman';" colspan="2">
            <div>Miscellaneous expenses (including amounts paid to FINRA, Nasdaq and the transfer agent)</div>
          </td>
          <td style="width: 21%; vertical-align: top; border-bottom: 2px solid black; text-align: center;">*</td>
        </tr>
        <tr>
          <td style="width: 79%; vertical-align: top; font-family: 'Times New Roman';" colspan="2">
            <div style="text-align: justify;">&#160;&#160;&#160;&#160;&#160;Total</div>
          </td>
          <td style="width: 21%; vertical-align: top; border-bottom: 4px double black;">
            <div><font style="font-family: 'Times New Roman';">$&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; &#160; </font>*<font style="font-family: 'Times New Roman';"></font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 79%; vertical-align: top;" colspan="2">
            <div style="text-align: justify; font-family: 'Times New Roman';">___________________________</div>
            <div style="font-family: 'Times New Roman';">*These fees will be dependent on the type of securities offered and number of offerings and, therefore, cannot be estimated at this time.</div>
            <div style="font-family: 'Times New Roman';">&#160;</div>
          </td>
          <td style="width: 21%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="font-weight: bold;">Item&#160;15.</div>
          </td>
          <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman';" colspan="2">
            <div style="font-weight: bold;">Indemnification of Directors and Officers.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman';" rowspan="1">&#160;</td>
          <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman';" colspan="2" rowspan="1">&#160;</td>
        </tr>

    </table>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">Section 78.7502(1) of the NRS provides that a corporation may, and the Registrant&#8217;s Amended and Restated Articles of Incorporation and
      By-Laws provide that the Registrant shall, indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (an
      &#8220;Action&#8221;), by reason of the fact that he is or was a director, officer, employee or agent of the corporation or is or was serving at the request of the corporation in such capacity in another corporation, partnership, joint venture, trust or other
      enterprise (the &#8220;Indemnified Party&#8221;), against expenses (including attorney&#8217;s fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him in connection with such action, suit or proceeding if he acted in good faith
      and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful; provided, however, no
      indemnification shall be made in respect of any Actions by or in the right of the corporation if the Indemnified Party shall have been adjudged by a court of competent jurisdiction, after exhaustion of any appeals, to be liable to the corporation,
      unless and only to the extent that the court shall determine that, despite the adjudication of liability but in view of all circumstances, such person is fairly and reasonably entitled to indemnity.&#160;&#160;</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">Under the NRS, the directors have a fiduciary duty to the Registrant that is not eliminated by this provision of the Articles and, in
      appropriate circumstances, equitable remedies such as injunctive or other forms of non-monetary relief will remain available.&#160;&#160;In addition, each director will continue to be subject to liability under the NRS for breach of the director&#8217;s duty of
      loyalty to the Registrant for acts or omissions which are found by a court of competent jurisdiction to not be in good faith or involve intentional misconduct, for knowing violations of law, for actions leading to improper personal benefit to the
      director, and for payment of dividends or approval of stock repurchases or redemptions that are prohibited by the NRS. This provision also does not affect the directors&#8217; responsibilities under any other laws, such as the federal securities laws or
      state or federal environmental laws.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">II-1</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a>
      <div><br>
      </div>
    </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">Furthermore, Section 78.7502(3) of the NRS provides that determination of an Indemnified Party&#8217;s eligibility for indemnification by the
      Registrant shall be made on a case-by-case basis by: (i) the stockholders; (ii) the board of directors by a majority vote of a quorum consisting of directors who were not parties to the act, suit or proceeding; (iii) independent legal counsel&#8217;s
      written opinion if: (1) a majority vote of a quorum consisting of directors who were not parties to the act, suit or proceeding so orders; or (2) a quorum consisting of directors who were not parties to the act, suit or proceeding cannot be obtained.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">Lastly, Section 78.752(1) of the NRS empowers a corporation to purchase and maintain insurance or make other financial arrangements with
      respect to liability arising out of the actions or omissions of directors, officers, employees or agents in their capacity or status as such, whether or not the corporation has the authority to indemnify him against such liability.&#160;&#160;</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">The Registrant&#8217;s Amended and Restated Articles of Incorporation (&#8220;Articles&#8221;) provide that, to the fullest extent permitted by the NRS, no
      director or officer shall be personally liable to the Registrant or to its stockholders for monetary damages for breach of fiduciary duty as a director or an officer, except to the extent that such exemption from liability or limitation thereof is
      not permitted under the NRS currently in effect or as the same may be amended.&#160; If the NRS is amended to further eliminate or limit or authorize corporate action to further eliminate or limit the liability of directors or officers, the liability of
      directors and officers of the Registrant shall be eliminated or limited to the fullest extent permitted by the NRS, as so amended from time to time.&#160; No repeal or modification of this provision of the Article will apply to or have any effect on the
      liability or alleged liability of any director or officer of the Registrant for or with respect to any acts or omissions of such directors or officers occurring prior to such repeal or modification.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">The Registrant&#8217;s Bylaws provide that the Registrant will indemnify and hold harmless any person who was or is a party or is threatened to be
      made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, in such manner, under such circumstances and to the fullest extent permitted by the Articles and the NRS.</div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="text-indent: 22.5pt; font-family: 'Times New Roman';">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling
      persons under the provisions discussed above or otherwise, we have been advised that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman'; font-weight: bold;">&#160;</font><font style="font-family: 'Times New Roman';">&#160;</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">II-2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div><a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a>
      <div><br>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z2ced197494934c33a72d56c42a98bbb6" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="font-weight: bold;">Item&#160;16.</div>
          </td>
          <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="font-weight: bold;">Exhibits.</div>
          </td>
        </tr>

    </table>
    <div style="font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="ze0823b010e194f5a8bcf749a103129cb" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman';">
            <div>(a)</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman';">
            <div>The following exhibits are filed as part of this registration statement:</div>
          </td>
        </tr>

    </table>
    <div style="font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z0ccdf0d5e4a3449e99a74746251f8416" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 18.94%; vertical-align: top; border-bottom: 2px solid black; font-family: 'Times New Roman';">
            <div>Exhibit No.</div>
          </td>
          <td style="width: 81.06%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        </tr>
        <tr>
          <td style="width: 18.94%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 18pt;"><a href="ex5_1.htm">5.1</a></div>
          </td>
          <td style="width: 81.06%; vertical-align: top; font-family: 'Times New Roman';">
            <div><a href="ex5_1.htm">Opinion of Certilman Balin Adler &amp; Hyman, LLP*</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 18.94%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 18pt;"><a href="ex23_1.htm">23.1</a></div>
          </td>
          <td style="width: 81.06%; vertical-align: top; font-family: 'Times New Roman';">
            <div><a href="ex23_1.htm">Consent of Friedman LLP*</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 18.94%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 18pt;"><a href="ex5_1.htm">23.2</a></div>
          </td>
          <td style="width: 81.06%; vertical-align: top; font-family: 'Times New Roman';">
            <div><a href="ex5_1.htm">Consent of Certilman Balin Adler &amp; Hyman, LLP </a>is included in the opinion of Certilman Balin Adler
              &amp; Hyman, LLP, filed as Exhibit 5.1.*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 18.94%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 18pt;"><a href="#POWEROFATTORNEY">24.1</a></div>
          </td>
          <td style="width: 81.06%; vertical-align: top; font-family: 'Times New Roman';">
            <div><a href="#POWEROFATTORNEY">Power of Attorney</a> (included in Part II as part of the signature page of the Registration Statement)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 18.94%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="margin-left: 18pt;"><a href="ex107.htm">107</a></div>
          </td>
          <td style="width: 81.06%; vertical-align: top; font-family: 'Times New Roman';">
            <div><a href="ex107.htm">Filing Fee Table*</a></div>
          </td>
        </tr>

    </table>
    <div style="font-family: 'Times New Roman';">&#160;__________</div>
    <div><font style="font-family: 'Times New Roman';"> <br>
      </font></div>
    <table cellspacing="0" cellpadding="0" id="zfa1423336a12421fa1b3a5728765d1e4" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 4%; vertical-align: top; font-family: 'Times New Roman';">
            <div>*</div>
          </td>
          <td style="width: 96%; vertical-align: top; font-family: 'Times New Roman';">
            <div>Filed herewith.</div>
          </td>
        </tr>

    </table>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z4a8b2a35fc0944aa81e4dd9f2b6238ef" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="font-weight: bold;">Item&#160;17.</div>
          </td>
          <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="font-weight: bold;">Undertakings.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman';" rowspan="1">&#160;</td>
          <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman';" rowspan="1">&#160;</td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">The undersigned registrant hereby undertakes:</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman';">(1)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">To file, during any period in which offers or sales are being made, a post-effective amendment to this
        registration statement:</font></div>
    <div style="text-indent: 72pt; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman';">(i)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</font></div>
    <div style="text-indent: 72pt; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman';">(ii)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">To reflect in the prospectus any facts or events arising after the effective date of the registration statement
        (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in
        volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus
        filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the
        effective registration statement; and</font></div>
    <div style="text-indent: 72pt; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman';">(iii)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">To include any material information with respect to the plan of distribution not previously disclosed in the
        registration statement or any material change to such information in the registration statement.</font></div>
    <div style="margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Provided</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">,<font style="font-style: italic;"> however</font>, that paragraphs (1)(i), (ii) and (iii) above do not apply if the information required to be included in a post-effective
        amendment by those paragraphs is contained in periodic reports filed with or furnished to the Securities and Exchange Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated
        by reference in this registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">II-3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a>
      <div><br>
      </div>
    </div>
    <div style="text-indent: 36pt; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman';">(2)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective
        amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div>
    <div style="text-indent: 36pt; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman';">(3)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">To remove from registration by means of a post-effective amendment any of the securities being registered which
        remain unsold at the termination of the offering.</font></div>
    <div style="text-indent: 36pt; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman';">(4)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:</font></div>
    <div style="text-indent: 72pt; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman';">(i)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">if the registrant is relying on Rule 430B:</font></div>
    <table cellspacing="0" cellpadding="0" id="z8b5df2a04c0845a581a9a720e1cdc388" class="DSPFListTable" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-bottom: 12pt;">

        <tr>
          <td style="width: 108pt; font-family: 'Times New Roman';"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman';">(A)</td>
          <td style="width: auto; vertical-align: top; font-family: 'Times New Roman';">
            <div>Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and</div>
          </td>
        </tr>

    </table>
    <div style="text-indent: 0pt; margin-left: 108pt; margin-bottom: 12pt; font-family: 'Times New Roman';">(B) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a
      registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii) or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act of 1933 shall be deemed to be part
      of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in
      Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which
      that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the
      registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to
      such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or</div>
    <div style="text-indent: 72pt; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman';">(ii)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">if the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a
        registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the
        date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into
        the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or
        prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">II-4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a>
      <div><br>
      </div>
    </div>
    <div style="text-indent: 36pt; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman';">(5)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any
        purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method
        used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or
        sell such securities to such purchaser:</font></div>
    <div style="text-indent: 72pt; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman';">(i)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be
        filed pursuant to Rule 424;</font></div>
    <div style="text-indent: 72pt; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman';">(ii)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or
        used or referred to by the undersigned registrant;</font></div>
    <div style="text-indent: 72pt; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman';">(iii)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">the portion of any other free writing prospectus relating to the offering containing material information about
        the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and</font></div>
    <div style="text-indent: 72pt; margin-bottom: 12pt;"><font style="font-family: 'Times New Roman';">(iv)</font><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; width: 36pt; font-family: 'Times New Roman';">&#160;</font><font style="font-family: 'Times New Roman';">any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</font></div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of
      1933, each filing of the registrant&#8217;s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of the
      Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be
      deemed to be the initial bona fide offering thereof.</div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors,
      officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as
      expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or
      controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the
      opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be
      governed by the final adjudication of such issue.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">II-5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;"><a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a>
      <div><br>
      </div>
    </div>
    <div style="text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman';">The undersigned registrant hereby undertakes that:</div>
    <table cellspacing="0" cellpadding="0" id="zd38582797c444cf8924c09ae96d1a838" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 14.54%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-indent: 36pt;">1)</div>
          </td>
          <td style="width: 85.46%; vertical-align: top; font-family: 'Times New Roman';">
            <div>For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained
              in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 14.54%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-indent: 36pt;">2)</div>
          </td>
          <td style="width: 85.46%; vertical-align: top; font-family: 'Times New Roman';">
            <div>For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the
              securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div>
          </td>
        </tr>

    </table>
    <div style="margin-bottom: 12pt; font-family: 'Times New Roman';"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;" class="BRPFPageNumber">II-6</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;"></div>
    </div>
    <div style="margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;"> <a href="#TABLEOFCONTENTS"><font style="font-weight: normal;">Table of Contents</font></a></div>
    <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman'; font-weight: bold;">SIGNATURES</div>
    <div style="text-indent: 36pt; margin-bottom: 8pt; font-family: 'Times New Roman';">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to
      believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Registration Statement on Form S-3 to be signed on its behalf by the undersigned, thereunto duly authorized, in Melville, New York, on February 6, 2023.</div>
    <table cellspacing="0" cellpadding="0" id="z6f287c2d136f401bb68aa68468d7101d" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 49.96%; vertical-align: top;">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;&#160;</font></div>
          </td>
          <td style="width: 50.04%; vertical-align: top; font-family: 'Times New Roman';" colspan="2">
            <div style="font-weight: bold;">BIORESTORATIVE THERAPIES, INC.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.96%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 50.04%; vertical-align: top; font-family: 'Times New Roman';" colspan="2">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.96%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 4.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>By:</div>
          </td>
          <td style="width: 45.54%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">/s/ Lance Alstodt</font><font style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.96%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 4.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 45.54%; vertical-align: top; font-family: 'Times New Roman';">
            <div>Lance Alstodt</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.96%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 4.5%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 45.54%; vertical-align: top; font-family: 'Times New Roman';">
            <div>President, Chief Executive Officer and Chairman of the Board</div>
          </td>
        </tr>

    </table>
    <div style="font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><a name="POWEROFATTORNEY"><!--Anchor--></a>POWER OF ATTORNEY</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;">&#160;</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Lance Alstodt as his true and lawful
      attorney-in-fact with full power of substitution and resubstitution for him and in his name, place and stead, in any and all capacities, to sign any and all amendments, including post-effective amendments to this registration statement, and any
      registration statement and amendments thereto for the same offering pursuant to Rule 462(b) of the Securities Act of 1933, as amended, and to file the same, with exhibits thereto, and other documents in connection therewith, with the Securities and
      Exchange Commission, hereby ratifying and confirming all that said attorneys-in-fact or their substitutes, each acting alone, may lawfully do or cause to be done by virtue hereof.</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-indent: 36pt; font-family: 'Times New Roman';">Pursuant to the requirements of the Securities Act of 1933, this Form S-3 has been signed by the following persons in the capacities and on the
      dates indicated.</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman';">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z8e24ce6e10c24810a6918e395d75d9f2" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 26.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
            <div style="text-align: center; font-weight: bold;">Signature</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">&#160;</div>
          </td>
          <td style="width: 49.02%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
            <div style="text-align: center; font-weight: bold;">Title</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">&#160;</div>
          </td>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
            <div style="text-align: center; font-weight: bold;">Date</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; font-weight: bold;">&#160;</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; font-weight: bold;">&#160;</div>
          </td>
          <td style="width: 49.02%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; font-weight: bold;">&#160;</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; font-weight: bold;">&#160;</div>
          </td>
          <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; font-weight: bold;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman'; font-style: italic;">/s/ Lance Alstodt</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 49.02%; vertical-align: top; font-family: 'Times New Roman';" rowspan="2">
            <div>President, Chief Executive Officer and Chairman of the Board (Principal Executive Officer)</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">&#160;</div>
          </td>
          <td style="width: 20%; vertical-align: top;" rowspan="2">
            <div style="text-align: center; font-family: 'Times New Roman';">&#160;February 6, 2023</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div>Lance Alstodt</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 49.02%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">&#160;</div>
          </td>
          <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
            <div style="font-style: italic;">/s/ Francisco Silva</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 49.02%; vertical-align: top; font-family: 'Times New Roman';" rowspan="2">
            <div>Vice President, Research and Development, Secretary and Director</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">&#160;</div>
          </td>
          <td style="width: 20%; vertical-align: top;" rowspan="2">
            <div style="text-align: center; font-family: 'Times New Roman';">&#160;February 6, 2023</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div>Francisco Silva</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="font-style: italic;">&#160;</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 49.02%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">&#160;</div>
          </td>
          <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
            <div style="font-style: italic;">/s/ Robert E. Kristal</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';" rowspan="2">&#160;</td>
          <td style="width: 49.02%; vertical-align: top; font-family: 'Times New Roman';" rowspan="2">
            <div>Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';" rowspan="2">&#160;</td>
          <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">February 6, 2023</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div>Robert E. Kristal</div>
          </td>
          <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        </tr>
        <tr>
          <td style="width: 26.99%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 49.02%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        </tr>
        <tr>
          <td style="width: 26.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
            <div style="font-style: italic;">/s/ Nickolay Kukekov</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 49.02%; vertical-align: top; font-family: 'Times New Roman';" rowspan="2">
            <div>Director</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">&#160;</div>
          </td>
          <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman';" rowspan="2">
            <div style="text-align: center;">February 6, 2023</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div>Nickolay Kukekov</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 49.02%; vertical-align: top; font-family: 'Times New Roman';">
            <div>&#160;</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">&#160;</div>
          </td>
          <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
            <div style="font-style: italic;">/s/ Patrick F. Williams</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';" rowspan="2">&#160;</td>
          <td style="width: 49.02%; vertical-align: top; font-family: 'Times New Roman';" rowspan="2">
            <div>Director</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';" rowspan="2">&#160;</td>
          <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">February 6, 2023</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div>Patrick F. Williams</div>
          </td>
          <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        </tr>
        <tr>
          <td style="width: 26.99%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 49.02%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        </tr>
        <tr>
          <td style="width: 26.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
            <div style="font-style: italic;">/s/ David Rosa</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';" rowspan="2">&#160;</td>
          <td style="width: 49.02%; vertical-align: top; font-family: 'Times New Roman';" rowspan="2">
            <div>Director</div>
          </td>
          <td style="width: 1.99%; vertical-align: top; font-family: 'Times New Roman';" rowspan="2">&#160;</td>
          <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center;">February 6, 2023</div>
          </td>
        </tr>
        <tr>
          <td style="width: 26.99%; vertical-align: top; font-family: 'Times New Roman';">
            <div>David Rosa</div>
          </td>
          <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        </tr>

    </table>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div style="font-family: 'Times New Roman';"><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div><br>
    </div>
    <br>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ex5_1.htm
<DESCRIPTION>CERTILMAN BALIN OPINION
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Certilman Balin Adler & Hyman, LLP
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>EXHIBIT 5.1</u></div>
    <div style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">&#160;</div>
    <div>
      <div style="text-indent: 36pt; margin-left: 180pt; font-family: 'Times New Roman',Times,serif;">February 6, 2023</div>
    </div>
    <div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="font-family: 'Times New Roman',Times,serif;">BioRestorative Therapies, Inc.</div>
      <div style="font-family: 'Times New Roman',Times,serif;">40 Marcus Drive, Suite 1</div>
      <div style="font-family: 'Times New Roman',Times,serif;">Melville, New York&#160; 11747</div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-indent: 36pt; font-family: 'Times New Roman',Times,serif;">Re:&#160;Registration Statement on Form S-3</div>
    </div>
    <div>
      <div><br>
      </div>
      <div style="font-family: 'Times New Roman',Times,serif;">Ladies and Gentlemen:</div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-indent: 36pt; font-family: 'Times New Roman',Times,serif;">We have acted as counsel to BioRestorative Therapies, Inc., a Nevada corporation (the "Company"), in connection with the Registration Statement on Form S-3 (the "Registration
        Statement"), including the prospectus constituting a part thereof (the "Prospectus"), filed by the Company with the Securities and Exchange Commission (the "Commission") under the Securities Act of 1933, as amended (the "Act") relating to&#160;the
        registration by the Company for the issue and sale by the Company from time to time of up to $75,000,000 offering price of (a)&#160;shares of the Company's common stock, $0.0001 par value per share (the "Common Stock"), (b) shares of the Company's
        preferred stock, $0.01 par value per share (the "Preferred Stock"), (c) debt securities of the Company ("Debt Securities"), (d) warrants for the purchase of Common Stock, Preferred Stock and/or Debt Securities (the &#8220;Warrants&#8221;) and (e) units
        comprised of Common Stock, Preferred Stock, Debt Securities and/or Warrants (the &#8220;Units&#8221;).&#160; The Prospectus provides that it may be supplemented in the future by one or more prospectus supplements (each, a "Prospectus Supplement").&#160;&#160;This opinion is
        being furnished in accordance with the requirements of Item&#160;16 of Form S-3 and Item&#160;601(b)(5) of Regulation S-K, as promulgated by the Commission.</div>
    </div>
    <div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; font-family: 'Times New Roman',Times,serif;">In connection with this opinion, we have examined the following documents: (i) the Amended and Restated Articles of Incorporation and the By-Laws of the Company, (ii) the
        Registration Statement, and (iii) a unanimous written consent of the Board of Directors of the Company relating to the filing of the Registration Statement.&#160; We have also examined such other instruments and documents as we deemed relevant under the
        circumstances.</div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-indent: 36pt; font-family: 'Times New Roman',Times,serif;">For purposes of this opinion, we have assumed (i) the authenticity of all documents submitted to us as original, (ii) the conformity to the originals of all documents
        submitted as certified, photostatic or facsimile copies and the authenticity of the originals, (iii) the legal capacity of natural persons, (iv) the due authorization, execution and delivery of all documents by all parties and the validity and
        binding effect thereof and (v) the conformity to the proceedings of the Board of Directors of all minutes of such proceedings.&#160; We have also assumed that the corporate records furnished to us by the Company include all corporate proceedings taken
        by the Company to date.</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-indent: 36pt; font-family: 'Times New Roman',Times,serif;">Based upon the foregoing and subject to the limitations, qualifications, exceptions and assumptions set forth herein, it is our opinion that:&#160;</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; font-family: 'Times New Roman',Times,serif;">(a) when an issuance of Common Stock has been duly authorized by all necessary corporate action of the Company, upon issuance, delivery and payment therefor in an amount not
        less than the par value thereof in the manner contemplated by the Prospectus or any Prospectus Supplement, and by such corporate action, and in total amounts and numbers of shares that do not exceed the respective total amounts and numbers of
        shares (i) available under the Amended and Restated Articles of Incorporation, and (ii) authorized by the Board of Directors in connection with the offering contemplated by the Prospectus or any Prospectus Supplement, such shares of Common Stock
        will be validly issued, fully paid and nonassessable;</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; font-family: 'Times New Roman',Times,serif;">(b) when a series of Preferred Stock has been duly established in accordance with the terms of the Company's Amended and Restated Articles of Incorporation and authorized by
        all necessary corporate action of the Company, upon issuance, delivery and payment therefor in an amount not less than the par value thereof in the manner contemplated by the Prospectus or any Prospectus Supplement and by such corporate action, and
        in total amounts and numbers of shares that do not exceed the respective total amounts and numbers of shares (i) available under the Amended and Restated Articles of Incorporation, and (ii) authorized by the Board of Directors in connection with
        the offering contemplated by the Prospectus or any Prospectus Supplement, such shares of such series of Preferred Stock will be validly issued, fully paid and nonassessable;</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; font-family: 'Times New Roman',Times,serif;">(c) with respect to the Debt Securities, when (i)&#160;the Debt Securities indenture and any and all applicable supplements thereto (the "Indenture") have been duly authorized,
        executed and delivered by the Company and duly qualified under the Trust Indenture Act of 1939, (ii)&#160;the Board of Directors has taken all necessary corporate action to approve the issuance and establish the terms of such Debt Securities, the terms
        of the offering and related matters, (iii)&#160;the Debt Securities have been duly executed and authenticated in accordance with the terms of the Indenture, and (iv)&#160;the Debt Securities have been issued and sold in the manner contemplated by the
        Registration Statement and in accordance with the Indenture, such Debt Securities (including any Debt Securities duly issued upon conversion, exchange or exercise of any other security in accordance with the terms of such security or the instrument
        governing such security providing for such conversion, exchange or exercise as approved by the Board of Directors) will be binding obligations of the Company and entitled to the benefits of the Indenture, except as may be limited by applicable
        bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer and similar laws affecting or relating to the rights of creditors generally, by general principles of equity (regardless of whether considered in a proceeding in equity or at
        law), and by requirements of reasonableness, good faith and fair dealing;</div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif;">(d) </font><font style="font-size: 10pt;">when an issuance of Warrants has been duly authorized by all necessary corporate
          action of the Company, upon issuance, delivery and payment therefor in the manner contemplated by the Prospectus or any Prospectus Supplement, and by such corporate action, and in numbers of Warrants that do not exceed the numbers of Warrants
          authorized by the Board of Directors in connection with the offering contemplated by the Prospectus or any Prospectus Supplement, such Warrants will be validly and binding obligations of the Company; and</font></div>
      <div><br>
      </div>
      <div style="text-indent: 36pt; font-family: 'Times New Roman',Times,serif;">(e) when an issuance of Units has been duly authorized by all necessary corporate action of the Company, upon issuance, delivery and payment therefor in the manner
        contemplated by the Prospectus or any Prospectus Supplement, and by such corporate action, and in numbers of Units that do not exceed the numbers of Units authorized by the Board of Directors in connection with the offering contemplated by the
        Prospectus or any Prospectus Supplement, such Units will be validly issued, fully paid and nonassessable.</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-indent: 36pt; font-family: 'Times New Roman',Times,serif;">We hereby consent to the filing of this opinion with the Commission as an exhibit to the Registration Statement and reference to our firm under the heading "Legal Matters" in
        the Prospectus.&#160; In giving such consent, we do not hereby admit that we are in the category of persons whose consent is required under Section&#160;7 of the Act or the rules and regulations of the Commission thereunder.</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-indent: 36pt; font-family: 'Times New Roman',Times,serif;">The opinion expressed herein is limited to the Nevada Revised Statutes, as currently in effect, and we express no opinion as to the effect of the laws of any other
        jurisdiction.</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-indent: 36pt; font-family: 'Times New Roman',Times,serif;">This opinion is as of the date hereof, and we do not undertake, and hereby disclaim, any obligation to advise you of any changes in any of the matters set forth herein.</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-indent: 36pt; font-family: 'Times New Roman',Times,serif;">We are rendering this opinion only as to the matters expressly set forth herein, and no opinion should be inferred as to any other matters.</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-indent: 36pt; font-family: 'Times New Roman',Times,serif;">This opinion is for your exclusive use only and is to be utilized and relied upon only in connection with the matters expressly set forth herein.</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-indent: 201.6pt; font-family: 'Times New Roman',Times,serif;">Very truly yours,</div>
    </div>
    <div>
      <div><br>
      </div>
    </div>
    <div>
      <div style="text-indent: 201.6pt; font-family: 'Times New Roman',Times,serif;">/s/ Certilman Balin Adler &amp; Hyman, LLP</div>
    </div>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ex23_1.htm
<DESCRIPTION>FRIEDMAN CONSENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Certilman Balin Adler & Hyman, LLP
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>EXHIBIT 23.1</u></div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM&#8217;S CONSENT</u></div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">We consent to the incorporation by reference in this Registration Statement of BioRestorative Therapies, Inc. on Form S-3 of our report dated March
      30, 2022, with respect to our audits of the consolidated financial statements of BioRestorative Therapies, Inc. as of December 31, 2021 and 2020 and for the years then ended, appearing in the Annual Report on Form 10-K of BioRestorative Therapies,
      Inc. for the year ended December 31, 2021. We also consent to the reference to our firm under the heading &#8220;Experts&#8221; in the Prospectus, which is part of this Registration Statement.</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">/s/ Friedman LLP</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">Friedman LLP</div>
    <div style="font-family: 'Times New Roman',Times,serif;">Marlton, New Jersey</div>
    <div style="font-family: 'Times New Roman',Times,serif;">February 7, 2023</div>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ex107.htm
<DESCRIPTION>FILING FEES TABLE
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Certilman Balin Adler & Hyman, LLP
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>EXHIBIT 107</u></div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Calculation of Filing Fee Tables</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">FORM S-3</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif;">(Form Type)</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">BIORESTORATIVE THERAPIES, INC.</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif;">(Exact Name of Registrant as Specified in its Charter)</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Table 1: Newly Registered Securities and Carry Forward Securities</div>
    <table cellspacing="0" cellpadding="0" id="za384fc02735f4dd483d10139c085519f" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 6.85%; vertical-align: bottom; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); text-align: center;">
            <div style="font-family: 'Times New Roman',Times,serif;">&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 7.63%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">Security</div>
            <div style="font-family: 'Times New Roman',Times,serif;">Type <br>
            </div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">&#160;</div>
          </td>
          <td style="width: 9.67%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">Security<br>
              Class</div>
            <div style="font-family: 'Times New Roman',Times,serif;">Title <br>
            </div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">&#160;</div>
          </td>
          <td style="width: 7.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">Fee<br>
              Calculation<br>
              or Carry<br>
              Forward<br>
              Rule</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">&#160;</div>
          </td>
          <td style="width: 6.77%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">Amount<br>
              Registered</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">&#160;</div>
          </td>
          <td style="width: 6.6%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">Proposed<br>
              Maximum<br>
              Offering<br>
              Price Per<br>
              Share</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">&#160;</div>
          </td>
          <td style="width: 9.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">Maximum</div>
            <div style="font-family: 'Times New Roman',Times,serif;">Aggregate</div>
            <div style="font-family: 'Times New Roman',Times,serif;">Offering</div>
            <div style="font-family: 'Times New Roman',Times,serif;">Price <br>
            </div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">&#160;</div>
          </td>
          <td style="width: 8.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">Fee<br>
              Rate</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">&#160;</div>
          </td>
          <td style="width: 7.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;"> <br>
            </div>
            <div style="font-family: 'Times New Roman',Times,serif;">Amount of<br>
              Registration</div>
            <div style="font-family: 'Times New Roman',Times,serif;">Fee <br>
            </div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">Carry<br>
              Forward<br>
              Form<br>
              Type</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">Carry<br>
              Forward<br>
              File<br>
              Number</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">&#160;</div>
          </td>
          <td style="width: 5.81%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">Carry<br>
              Forward<br>
              Initial<br>
              Effective<br>
              Date</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">&#160;</div>
          </td>
          <td style="width: 7.29%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">Filing Fee<br>
              Previously<br>
              Paid In<br>
              Connection<br>
              with Unsold<br>
              Securities<br>
              to be<br>
              Carried<br>
              Forward</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="25">
            <div style="text-align: center;">Newly Registered Securities</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.85%; vertical-align: middle; border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 8.1%; vertical-align: middle;" colspan="2">
            <div>&#160;</div>
          </td>
          <td style="width: 10.14%; vertical-align: middle;" colspan="2">
            <div>&#160;</div>
          </td>
          <td style="width: 7.75%; vertical-align: middle;" colspan="2">
            <div>&#160;</div>
          </td>
          <td style="width: 7.24%; vertical-align: middle;" colspan="2">
            <div>&#160;</div>
          </td>
          <td style="width: 7.06%; vertical-align: middle;" colspan="2">
            <div>&#160;</div>
          </td>
          <td style="width: 10.19%; vertical-align: middle;" colspan="2">
            <div>&#160;</div>
          </td>
          <td style="width: 8.75%; vertical-align: middle;" colspan="2">
            <div>&#160;</div>
          </td>
          <td style="width: 8.19%; vertical-align: middle;" colspan="2">
            <div>&#160;</div>
          </td>
          <td style="width: 5.85%; vertical-align: middle;" colspan="2">
            <div>&#160;</div>
          </td>
          <td style="width: 5.85%; vertical-align: middle;" colspan="2">
            <div>&#160;</div>
          </td>
          <td style="width: 6.27%; vertical-align: middle;" colspan="2">
            <div>&#160;</div>
          </td>
          <td style="width: 7.76%; vertical-align: middle;" colspan="2">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.85%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">Fees to Be<br>
              Paid</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.63%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">Equity</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 9.67%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">Common</div>
            <div style="text-align: center;">Stock,</div>
            <div style="text-align: center;">par value</div>
            <div style="text-align: center;">$0.0001</div>
            <div style="text-align: center;">per share</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">457(o)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 6.77%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">(1)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 6.6%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">(2)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 9.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 8.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 7.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.81%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 7.29%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.85%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.63%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">Equity</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 9.67%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); text-align: center; border-right: 2px solid rgb(0, 0, 0);">
            <div style="font-family: 'Times New Roman',Times,serif;">Preferred</div>
            <div style="font-family: 'Times New Roman',Times,serif;">Stock,</div>
            <div style="font-family: 'Times New Roman',Times,serif;">par value</div>
            <div style="font-family: 'Times New Roman',Times,serif;">$0.01</div>
            <div>per share <br>
            </div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">457(o)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 6.77%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">(1)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 6.6%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">(2)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 9.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 8.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 7.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.81%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 7.29%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.85%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td nowrap="nowrap" style="width: 7.63%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">Equity</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 9.67%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">Warrants</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">457(o)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 6.77%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">(1)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 6.6%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">(2)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 9.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 8.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 7.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 5.81%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 7.29%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6.85%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.63%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">Equity</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 9.67%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">Units</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">457(o)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 6.77%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">(1)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 6.6%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">(2)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 9.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 8.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 7.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.81%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 7.29%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.85%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td nowrap="nowrap" style="width: 7.63%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">Debt</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 9.67%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">Debt Securities</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">457(o)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 6.77%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">(1)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 6.6%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">(2)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 9.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 8.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 7.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 5.81%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 7.29%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6.85%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.63%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">Unallocated</div>
            <div style="text-align: center;">(Universal)</div>
            <div style="text-align: center;">Shelf&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 9.67%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">457(o)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 6.77%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">(1)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 6.6%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">(2)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 9.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">$75,000,000(2)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 8.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">$0.00011020</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">$8,265(3)</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.81%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 7.29%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.85%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">Fees Previously Paid</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.63%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 9.67%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 6.77%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 6.6%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 9.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 8.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.81%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 7.29%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);" colspan="25">
            <div style="text-align: center;">Carry Forward Securities</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.85%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">Carry Forward Securities</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.63%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 9.67%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 7.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 6.77%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 6.6%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 9.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 8.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 5.81%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.29%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.85%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 32.77%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);" colspan="7">
            <div style="text-align: center;">Total Offering Amounts</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 6.6%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 9.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">$75,000,000</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 8.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">$8,265</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.81%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 7.29%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.85%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 32.77%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);" colspan="7">
            <div style="text-align: center;">Total Fees Previously Paid</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 6.6%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 9.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 8.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.81%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 7.29%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.85%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 32.77%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);" colspan="7">
            <div style="text-align: center;">Total Fee Offsets</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 6.6%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 9.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 8.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">&#8212;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.81%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 7.29%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 6.85%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 32.77%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);" colspan="7">
            <div style="text-align: center;">Net Fees Due</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 6.6%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 9.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 8.28%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td nowrap="nowrap" style="width: 7.72%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">$8,265</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 5.81%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 0.47%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
          <td style="width: 7.29%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
            <div>&#160;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5221e6cde18e4ac2a5e99080cffe1acd" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 5.24%; vertical-align: top;">
            <div>(1)</div>
          </td>
          <td style="width: 94.76%; vertical-align: top;">
            <div>There are being registered hereunder such indeterminate number of shares of common stock, such indeterminate number of shares of preferred stock, such
              indeterminate number of warrants to purchase common stock, such indeterminate number of units consisting of common stock and/or warrants and such indeterminate
                principal amount of debt securities as shall have an aggregate initial offering price not to exceed $75,000,000. The securities registered also include such indeterminate number of shares of common stock as may be issued upon
              exercise of or upon conversion of warrants or pursuant to the antidilution provisions of any such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), the shares being registered
              hereunder include such indeterminate number of shares of common stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5.24%; vertical-align: top;">
            <div>(2)</div>
          </td>
          <td style="width: 94.76%; vertical-align: top;">
            <div>The proposed maximum aggregate offering price per class of security will be determined from time to time by the registrant in connection with the
              issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to Instruction 2.A.iii.b. to the Calculation of Filing Fee Tables and Related Disclosure on Item 16(b) of Form S-3
              under the Securities Act.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 5.24%; vertical-align: top;">
            <div>(3)</div>
          </td>
          <td style="width: 94.76%; vertical-align: top;">
            <div>Calculated pursuant to Rule 457(o) under the Securities Act based on the maximum aggregate offering price.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div>&#160;</div>
    <div><br>
    </div>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
